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ABSTRACT
MODULATION OF L-TYPE CALCIUM CURRENT BY
GABAB RECEPTOR ACTIVATION IN THE
NEONATAL RAT HIPPOCAMPUS

Jennifer G. Bray, B.S.
Marquette University, 2010

During the early postnatal period, the inhibitory neurotransmitter γ-aminobutyric
acid (GABA) facilitates current through voltage-dependent L-type calcium channels by
activating metabotropic GABAB receptors in the rat hippocampus. In the present study,
the effects of the GABAB receptor agonist baclofen on L-type currents were tested using
whole-cell voltage clamp recording on neurons isolated from the superior region of
hippocampi obtained from pups of various ages to determine the exact time course of Ltype current facilitation. The facilitation of L-type current by GABAB receptors is more
prominent during the second week of development.
One developmental process that L-type current may be involved in is changes in
the expression of the K+Cl- co-transporter (KCC2) and N+K+2Cl- co-transporter
(NKCC1), which are necessary in the maturation of the GABAergic system. To
investigate whether calcium influx through L-type channels and GABAB receptor
activation affects the expression of chloride transporters during the early neonatal period,
hippocampal cultures isolated from day 0 pups were treated with a GABAB agonist or an
L-type channel antagonist for one week. Steady state KCC2 and NKCC1 levels were
determined by Western blot analysis. Blockade of L-type channels drastically reduced
KCC2 expression but not NKCC1 expression, suggesting that the upregulation of KCC2
in the first postnatal week is dependent on calcium influx through L-type channels.
The involvement of protein kinase C (PKC) and A (PKA) in the signaling
pathway of L-type current modulation by GABAB receptors was also investigated using
electrophysiological experiments. The facilitatory response of baclofen was blocked in
the presence of PKC inhibitors, but not PKA inhibitors. Direct activation of PKC using a
phorbol ester mimicked the facilitation of L-type current seen with baclofen, whereas
facilitation was not seen with direct activation of PKA with a cAMP analogue. Together,
these experiments have demonstrated that the facilitation of L-type current by GABAB
receptor activation is maximal during the second postnatal week in development and is
mediated by PKC. In addition, calcium influx through L-type channels also contributes
to the maturation of the GABAergic system.
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CHAPTER 1
INTRODUCTION
Understanding the function and regulation of voltage-dependent calcium channels
(VDCC) is important because influx of calcium plays a fundamental role in the regulation
of many cellular processes within the central nervous system (CNS). Calcium influx is
crucial for the propagation of some action potentials, changes in synaptic plasticity, the
release of neurotransmitters, and for the expression of certain genes (for review see West
et al., 2001; Catterall and Few, 2008; Neher and Sakaba, 2008; Gover et al., 2009).
Calcium signaling is not only important in processes of mature neurons, but it also plays
a critical role in the differentiation, growth, and maturation of developing neurons. Due
to the importance of calcium as an intracellular messenger, calcium channels are often
regulated by neurotransmitters. One of the most common neurotransmitters that has been
shown to modulate several types of calcium channels is γ-aminobutyric acid (GABA).
Many inhibitory interneuron subtypes within the hippocampus utilize GABA to regulate
the overall excitability of the hippocampal region.
Previous studies in the Mynlieff laboratory have shown modulation of calcium
current by baclofen, a GABAB receptor agonist (Carter and Mynlieff, 2004). In acutely
cultured hippocampal neurons isolated from 1 week old neonatal rat pups, N-type
calcium current decreases in response to activation of GABAB receptors. In a subset of
cells, L-type calcium current increases in response to activation of GABAB receptors.
The facilitation of L-type current by GABAB receptors had not been previously observed
in the mammalian nervous system. Thus, this phenomenon became an area of particular
interest in the laboratory.
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The focus of my studies has been to investigate the phenomenon of L-type
calcium current facilitation by GABAB receptor activation in the rat hippocampus, a
phenomenon that has only been demonstrated in hippocampal cultures isolated from
neonates. The first goal of this project was to establish the exact time course of L-type
calcium current facilitation by GABAB receptor activation during the first two weeks of
development in the rat hippocampus. In addition, the functional significance of L-type
calcium current modulation on the expression levels of chloride transporters during
development was investigated as well as the second messenger systems involved in Ltype calcium current modulation by GABAB receptors. A better understanding of the
importance of GABAB receptors in the development of a mature nervous system can be
achieved by increasing our knowledge of GABAB receptor modulation of calcium
channels.

Voltage-Dependent Calcium Channels
Calcium channels have been classified into different subtypes according to
voltage dependence, kinetics, pharmacology, and molecular biology. VDCCs can be
characterized by channel activation into two different subgroups, low voltage-activated
(LVA) and high voltage-activated (HVA) channels (Carbone and Lux, 1984; Bean,
1989a). LVA channels are activated at low voltages and produce a transient current (Ttype channels; Nowycky et al., 1985; Bean and McDonough, 1998). HVA channels have
been further divided into 5 different subgroups (L-type, P-type, Q-type, N-type, and Rtype) based on pharmacology, kinetics, and molecular identification of the α1 subunit (for
review see Tsien et al., 1988; Ertel et al., 2000; Lipscombe, 2004).
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Experiments in the laboratory have primarily focused on L-type calcium channels,
which are found in neurons and different muscle types. Neuronal voltage-dependent Ltype calcium channels are heteromeric complexes that contain an α1 pore forming
subunit, and several auxiliary subunits including an extracellular α2 subunit, an
intracellular β subunit, and a transmembrane δ subunit (Figure 1.1; for review see
Figure 1.1: Structure of neuronal L-type calcium
channels. The channel is made up of four subunits.
The α1 subunit forms the channel pore. The α2δ
subunit associates with the α1 subunit to modulate
current amplitude. The intracellular β subunit
regulates the activation, inactivation, current, and
voltage dependence of the α1 subunit (Singer et al.,
1991).

Catterall, 1998, 2000). The α2δ and β auxiliary subunits modulate the trafficking and
control the function of the α1 subunit (Singer et al., 1991). The α1subunit is made up of 4
domains with each domain containing six transmembrane spanning segments (Figure 1.2;
Catterall, 2000). Due to its role as the conduction pore, gating apparatus, and voltage

Figure 1.2: Structure of the α1 subunit of VDCCs. The amino acid sequence for the α1 subunit is
approximately 2000 residues long and is organized in four repeated domains, each of which
contain 6 transmembrane segments (S1 – S6). The S4 transmembrane segment contains several
positively charged amino acids and is thought to be the voltage sensor. The N- and C- termini are
cytoplasmic. The cytoplasmic regions are key sites for phosphorylation by kinases. Figure
obtained from Tedford and Zamponi, 2006.
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sensor, the α1 subunit is a major site of regulation by drugs, toxins, and phosphorylation
by protein kinase C (PKC), protein kinase A (PKA), and Ca2+/calmodulin-dependent
protein kinase II (CaMKII; for review see Catterall 1998, 2000).
Functional Identification Molecular Identification Pharmacological Antagonists
HVA L-type
Cav 1.1, 1.2,1.3, 1.4
Dihydropyridines
HVA P/Q-type
Cav 2.1
ω-Agatoxin IVA
HVA N-type
Cav 2.2
ω-Conotoxin GVIA
HVA R-type
Cav 2.3
Nickel, SNX-483
LVA T-type
Cav 3.1,3.2,3.3
Nickel, amiloride
Table 1: Summary of the identification and nomenclature of VDCCs. To distinguish between the
various types of calcium channels different channels blockers can be used (Adapted from Ertel et
al., 2000).

Currently, ten pore-forming α1 subunits have been cloned and are used to further
classify calcium channels into 3 different families Cav1, Cav2, and Cav3 (Table 1; Ertel et
al., 2000; Lipscombe et al., 2004). The Cav1 family of α1 subunits consists of several
subtypes of L-type calcium channels, which produce long lasting calcium currents.
These types of channels have relatively slow activation and inactivation kinetics, with
some subtypes demonstrating calcium-dependent inactivation along with voltagedependent inactivation (for review see Lipscombe et al., 2004). Cav1.1 channels are
found in skeletal muscle where they are linked to ryanodine receptors in the sarcoplasmic
reticulum. Cav1.2 channels are found in cardiac and smooth muscle where they initiate
muscle contraction, in neurons where they are involved in gene regulation, and in
endocrine cells where they aid in secretion (for review see McDonald et al., 1994;
Catterall, 2000; Lipscombe et al., 2004). Cav1.3 channels have similar expression as Cav
1.2 channels and are expressed in neurons, cardiac muscle, and endocrine cells. Cav1.4
L-type calcium channels are located in retinal tissue and are linked to phototransduction
(Baumann et al., 2004). Cav1.2 and Cav1.3 L-type calcium channels are both located on
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the soma and dendrites of neurons (Westenbroek et al., 1990; Budde et al., 1998; McRory
et al., 2004). These neuronal types of L-type calcium channels are modulated by protein
phosphorylation and regulate a number of processes such as activity-dependent gene
expression, mRNA stability, neuronal survival, synaptic efficacy, and the activity of
neighboring ion channels (Murphy et al., 1991; Bading et al., 1993; Christie et al., 1995;
Finkbeiner and Greenberg, 1998; Hardingham et al., 1998; Marrion and Tavalin, 1998;
Charles et al., 1999; Schorge et al., 1999; Dolmetsch et al., 2001; Marshall et al., 2003;
for review see Lipscombe, 2004; Pinato et al, 2009).
The Cav2 family consists of N-type, P/Q-type, and R-type calcium channels.
These channels are most commonly found in neurons and regulate the release of
neurotransmitters within synapses. T-type calcium channels make up the Cav3 family of
α1 subunits. T-type calcium channels, which can be found in the brain, heart, kidney, and
liver play an important role in regulating overall cell excitability and hormone secretion
(for review see Cueni et al., 2009; Iftinca and Zamponi, 2009). The HVA Cav1 and Cav2
calcium channels are primarily distinguished from one another in native neurons through
pharmacological methods. L-type calcium channels are sensitive to dihydropyridines
(DHP), whereas P/Q-type calcium channels are blocked by varying concentrations of a
spider venom toxin ω-agatoxin IVA. N-type calcium channels are blocked by the conesnail toxin ω-conotoxin GVIA and can not be blocked by DHP antagonists or activated
by DHP agonists (Table 1; Fox, 1987; Cruz et al., 1987; Tsien et al., 1988; Bean, 1991;
Mintz et al., 1992).
The use of heterologous expression systems to study calcium channel properties
has given a wealth of information characterizing the different calcium channel subtypes.
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When Cav1.1 L-type calcium channels were expressed in muscle cells from dysgenic
mice, the currents were small and demonstrated slow activation kinetics (Tanabe et al.,
1988; Adams et al., 1990). In comparison, when Cav1.2 L-type calcium channels were
expressed, the activation kinetics were faster than seen with the Cav1.1 (Tanabe et al.,
1990). Further heterologous expression studies have demonstrated different activation
thresholds between Cav1.2 and Cav1.3 L-type calcium channels, with Cav1.3 channels
exhibiting a lower activation threshold than Cav1.2 channels (Safa et al., 2001; Scholze et
al., 2001; Xu and Lipscombe, 2001). Cav1.3 channels begin to activate at potentials
around -55 mV, whereas Cav1.2 channels begin to activate closer to -30 mV. This
suggests that Cav1.3 channels, but not Cav1.2 channels, may activate at subthreshold
depolarizations. The differences in activation suggest that Cav1.3 and Cav1.2 may
function in different signaling pathways within neurons. Calcium channels belonging to
the Cav2 family can be distinguished from L-type calcium channels, because they require
stronger depolarizations for activation (positive to -20 mV) and demonstrate moderate
voltage-dependent inactivation (Tsien et al., 1988; Fujita et al., 1993; Delcour et al.,
1993).

The Hippocampus
The hippocampus is a region of the brain that plays a prominent role in spatial
learning and in the formation and retrieval of memories (for review see Bird and Burgess,
2008; Neves et al., 2008; Cutsuridis and Wennekers, 2009; Eichenbaum and Fortin,
2009). The hippocampus is also involved in the formation and spread of seizures
(Falconer et al., 1964; Dam, 1980, 1982; Schwartzkroin, 1994). As a result of seizure
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activity, several structural and functional changes occur in the neuronal connectivity of
the hippocampus (for review see Lado et al., 2002; Naegele, 2009). This hippocampal
damage can lead to recurrent seizures and ultimately may result in the development of
epilepsy (Sutula et al., 1989; Overstreet-Wadiche et al., 2006).
As one of the most studied brain regions, the cell types of the hippocampus and
their network connections have been characterized relatively well. The hippocampus is a
highly organized structure that is divided into three major regions called the dentate
gyrus, the CA3, and the CA1. The hippocampus acts as a unidirectional circuit that
allows information to flow into, through, and then out to other neurons throughout the
brain (Andersen et al., 1973). There are three major excitatory synaptic connections
within the hippocampus (Figure 1.3). The main input into the hippocampus is through
the perforant pathway in which axons from the entorhinal cortex project onto granule
cells in the dentate gyrus. The mossy fiber pathway extends from granule cell axons that
synapse onto pyramidal cells within the CA3 region. The Schaffer collateral pathway
consists of axons from the CA3 pyramidal cells that project onto pyramidal cells within
the CA1 region. The principle output from the hippocampus occurs through CA1 axons,
which project to the subiculum and back to the entorhinal cortex (Amaral, 1993; Braak et
al., 1996).

CA1
CA3

DG

Figure 1.3: The Hippocampal Network.
Input from the entorhinal cortex forms
connections with the dentate gyrus (DG)
through the perforant path. Granule cell
axons in the dentate gyrus project to the
CA3, which in turn projects to the CA1
through the Schaffer collateral pathway.
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The overall excitability of the adult hippocampus is regulated by local inhibitory
interneurons, which control the number of active pyramidal cells and their firing pattern
by releasing the inhibitory neurotransmitter GABA. Pyramidal cells are modulated by a
diverse population of GABAergic interneurons. There are over 21 distinguishable
inhibitory interneurons that synapse either on specific regions of CA1 pyramidal cells or
onto other interneurons (for review see Somogyi and Klausberger, 2005; Ascoli et al.,
2008; Klausberger and Somogyi, 2008; Cutsuridis and Wennekers, 2009; Klausberger,
2009). These interneurons are classified based on their anatomical, morphological, and
physiological characteristics along with antibody staining. Although the importance of
interneurons in hippocampal functioning is clear, very little is known about the
mechanisms involved in the maturation of inhibitory interneurons and synapses within
the hippocampus. The experiments described here contribute to our knowledge of
hippocampal development by investigating GABAB receptor facilitation of L-type
calcium current during the maturation of the GABAergic circuitry within the neonatal rat
hippocampus.
The hippocampus appears to be involved in severe illnesses such as
schizophrenia, depression, bipolar disorder, and epilepsy. Seizures are more likely to
occur in immature humans and animals, and in humans seizure susceptibility peaks
during the first few months after birth (Sperber, 1999; for review see Lado et al., 2002;
Holopainen, 2008; Rakhade and Jensen, 2009). This is most likely due to the fact that the
inhibitory GABAergic system within the hippocampus is not yet fully developed and thus
neurons are highly excitable due to the lack of inhibition. In addition, at least in rat
hippocampus, the response to GABA is excitatory during the first few postnatal weeks.
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Therefore, it is essential to understand the time course and mechanisms involved in the
development of the hippocampus and the GABAergic system to aid in the treatment of
early onset seizures.

GABA Receptors
The importance of calcium influx in neuronal function makes calcium channels a
prime site for neurotransmitter modulation. One neurotransmitter within the mammalian
CNS that can regulate calcium channels is GABA. GABA is the major inhibitory
neurotransmitter in the mammalian CNS. It acts by binding to specific receptors, which
produces a variety of cellular effects in both presynaptic and postsynaptic neurons.
GABA receptors have been classified into 3 different subtypes, GABAA, GABAB, and
GABAC. The ionotropic GABAA and GABAC receptors have an ion channel
incorporated into the receptor and mediate fast inhibitory synaptic transmission (Figure
1.4). When GABA binds to the receptor it causes a conformational change that allows
chloride ions to flow through the channel causing the cell to hyperpolarize, which
prevents it from reaching threshold. GABAB receptors are metabotropic and mediate
their effects through G-proteins (Figure 1.4). Compared to the ligand-gated GABAA and
GABAC channels, the effects of GABAB receptor activation are slower and often involve
the regulation of calcium or potassium channels.
GABAB receptors are expressed on neurons both presynaptically, where they
modulate neurotransmitter release and postsynaptically, where they modulate neuronal
excitability. Functional GABAB receptors are heterodimeric complexes of two
homologous subunits, GABAB1 and GABAB2 (Kaupmann et al., 1997, 1998; Jones et al.,
1998; White et al., 1998; Kuner et al., 1999; Ng et al., 1999; White et al., 2002).
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GABAA/C Receptor

GABAB Receptor

GABAB1

GABAB2

G
Figure 1.4: GABA Receptors. GABAA and GABAC receptors are ionotropic and form a channel
that is permeable to chloride ions. GABAA receptors are pentameric structures that can be
assembled from a number of different subunits (α, β, γ, δ, and ρ). The most common GABAA
receptor found in the brain is composed of 2α:2β:1γ. GABAC receptors, which are constructed
from ρ subunits, are insensitive to bicuculline and are found only in the retina. GABAB receptors
are heterodimers, consisting of GABAB1 and GABAB2 subunits. GABAB receptors are
metabotropic and are coupled to G-proteins and often regulate K+ and Ca2+ channels.

There are two different isoforms of the GABAB1 subunit, GABAB1a and GABAB1b.
These two isoforms are differentially localized within the hippocampus where GABAB1a
is located presynaptically, while GABAB1b is primarily located postsynaptically (Vigot et
al., 2006). In order for GABAB receptors to be functional, the GABAB1 and the GABAB2
subunits must form a dimer and be inserted into the membrane. It is thought that Gprotein coupled receptors (GPCRs) form dimers to increase their surface area so that it is
possible to interact with trimeric G-protein complexes (Bouvier, 2001; Hamm, 2001). To
ensure that the complexes are assembled properly before being inserted into the
membrane, GABAB receptors must first pass a dimerization-dependent trafficking
checkpoint (Margeta-Mitrovic et al., 2000; Pagano et al., 2001). Once functional
heterodimeric GABAB receptors are inserted into the plasma membrane, agonists are able
to bind to the ligand binding domain located on the large extracellular N-terminus of the
GABAB1 subunit (Galvez et al., 1999; 2000a; 2000b). Ligand binding causes a
conformational change in the GABAB2 subunit, which results in G-protein coupling and
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activation. Subsequently, activated G-proteins are able to modulate downstream
signaling pathways (Figure 1.5).
GABAB2

Ca2+ Channels
K+ Channels
Adenylyl Cyclase

GABAB1

GABAB2
GABAB1

GABA/Ca2+

Figure 1.5: Structure of GABAB receptors. GABAB1 and GABAB2 heterodimers
are trafficked and inserted into the plasma membrane. Activation of GABAB1 by
GABA binding to the N-terminus results in a conformational change in the
GABAB2 subunit, which allows recruitment and activation of G-proteins. Figure
obtained from Enna, 2001.

GABAB receptors are commonly coupled to Gαi and Gαo proteins (Asano and
Ogasawara, 1986; Morishita et al., 1990; Campbell et al., 1993; Menon-Johansson et al.,
1993; Greif et al., 2000; Bettler et al., 2004). Modulation of ion channels and other
downstream effectors can either occur via the α subunit or βγ subunits. Inhibition of Ntype and P/Q-type calcium current by presynaptic GABAB receptor activation occurs
through the Gβγ subunits that are associated with Gαi and Gαo proteins (Scholz and
Miller, 1990; Menon-Johansson et al., 1993; Mintz and Bean, 1993; Pfrieger et al., 1994;
Amico et al., 1995; Cardozo and Bean, 1995; Poncer et al., 1997; Kajikawa et al., 2001;
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for review see Bettler et al., 2004). Inhibition of N-type and P/Q-type calcium channels
in the presynaptic terminal following GABAB receptor activation will ultimately lead to a
decrease in neurotransmitter release (Hirata et al., 1995; Doze et al., 1995; Takahashi et
al., 1998). Postsynaptic GABAB receptor activation of inwardly rectifying K+ current
occurs through the Gβγ subunits that are associated with Gαi and Gαo proteins and results
in the hyperpolarization of the postsynaptic cell (Gähwiler and Brown, 1985; Lüscher et
al., 1997; Kaupmann et al., 1998; Yamada et al., 1998; for review see Bettler et al.,
2004).
Using GABAB receptor knockout mice, it has been demonstrated that GABAB
receptors are critically involved in neuronal development. GABAB receptor mutations or
loss of functional GABAB receptors can lead to a number of abnormalities during
development. In the absence of functional GABAB1 subunits (site of GABA binding)
neuronal excitability is not under control and mice exhibit epilepsy by postnatal week 2,
hyperalgesia, hyperlocomotor activity, and have an impaired memory (Prosser et al.,
2001; Schuler et al., 2001). The mean average life expectancy of GABAB1 knockout
mice is 21 days (Prosser et al., 2001). Mice that lack GABAB2 subunits have similar
symptoms as mice lacking GABAB1 subunits, which is consistent with the heterodimeric
structure of GABAB receptors (Gassmann et al., 2004; Mombereau et al., 2005). In
comparison to the severe deficits seen in GABAB1 or GABAB2 knockout mice, adult
animals treated with acute or chronic GABAB receptor antagonists do not develop such
extreme behavioral changes (Bittiger et al., 1993; Mondadori et al., 1993; Vergnes et al.,
1997). Although it is hard to get complete blockage of GABAB receptors in vivo, these
experiments are suggestive that GABAB receptors may be critically involved in the
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development of a mature nervous system. Therefore, it is essential to understand the role
that GABAB receptors play in the development of neurons particularly within the
hippocampus, where several of the behavioral deficits seen in the GABAB1 and GABAB2
knockout mice arise.

GABA Function During Development
It is well documented that GABA exerts an excitatory rather than inhibitory
response early in neuronal development due to the high concentration of intracellular
chloride ions (Mueller et al., 1984; Ben-Ari et al., 1989; Cherubini et al., 1991; Luhmann
and Prince, 1991; Gaiarsa et al., 1995; Owens et al., 1999). During neuronal maturation
GABAA receptor activation depolarizes the membrane. This GABA-induced
depolarization shifts to a hyperpolarizing effect in the first few postnatal weeks due to a
change in the reversal potential of chloride (Cherubini et al., 1990; Luhmann and Prince,
1991; Chen et al., 1996; Owens et al., 1999). The developmental switch of the
GABAergic system has been demonstrated in both cultured hippocampal neurons as well
as in hippocampal slices (Rivera et al., 1999; Ganguly et al., 2001). It is believed that the
upregulation of the K+Cl- co-transporter, KCC2, and the downregulation of the, N+K+2Clco-transporter, NKCC1, may be responsible for shifting the chloride reversal potential in
immature neurons (Plotkin et al., 1997; Lu et al., 1999; Rivera et al., 1999; Vu et al.,
2000; Hübner et al., 2001a). NKCC1 expression predominates in immature neurons and
mediates chloride influx, while KCC2 expression predominates in mature neurons and
mediates chloride efflux (Figure 1.6; for review see Delpire, 2000; Payne et al., 2003).

14

Early Postnatal

Adult

KCC2

KCC2

K+

GABAA

GABAA

Cl-

Na+/K+
NKCC1
Cl-

Cl-

GABAB

K+

Na+/K+
NKCC1
Cl-

Cl-

GABAB

Cl-

L-channel

Cl-

Cl-

ClC2

L-channel

ClC2

Ca2+

Low KCC2 expression,
high NKCC1 expression
High Chloride

High KCC2 expression,
Low NKCC1 expression
Low Chloride

Figure 1.6: Maturation of the GABAergic system. In immature neurons the intracellular chloride
concentration is kept relatively high due to the expression of NKCC1, which pumps chloride into
the cell. GABAA receptor activation results in an efflux of chloride and excites the cell. In
comparison, KCC2 expression predominates in mature neurons and mediates chloride efflux.
GABAA receptor activation results in an influx of chloride and inhibits adult neurons. Figure
adapted with permission from Fukuda et al., 1998. Abbreviations: KCC2, K+ Cl- co-transporter;
NKCC1, Na+ K+ 2Cl- co-transporter; ClC2, voltage-dependent chloride channel; L-channel,
voltage-dependent L-type calcium channel.

There are nine types of cation chloride transporters (CCCs) found in mammals.
There are two NKCCs (NKCC1 and NKCC2), four KCCs (KCC1-4), one Na+Cl- (NCC),
and two additional CCCs (ClP1 and CCC9; for review see Delpire, 2000; Blaesse et al.,
2009). NCC and NKCC2 are renal specific (for review see Knepper and Brooks, 2001;
Castrop and Schnermann, 2008), whereas KCC2 is neuron specific (Payne et al., 1996;
Lu et al. 1999). NKCC1 is expressed in neurons and also glial cells within the CNS
(Kanaka et al., 2001; Hübner et al., 2001b). The three other types of KCCs (KCC1,
KCC3, and KCC4) are expressed in various tissues including neurons, muscle, and the
kidney (for review see Payne et al., 2003; Blaesse et al., 2009). CCC activity can be
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regulated through phosphorylation by kinases. For example, NKCC1 activation occurs
through phosphorylation of a regulatory domain in its N-terminus (Darman and Forbush,
2002; Flemmer et al., 2002). The two predominant CCCs within hippocampal neurons
are KCC2 and NKCC1, however their expression levels are developmentally regulated
during the first few postnatal weeks.
Due to the high intracellular chloride concentration in immature neurons, the
activation of GABAA receptors causes an efflux of chloride, which depolarizes the cell.
If sufficiently depolarized VDCCs will be activated leading to an increase of L-type
calcium current. Using calcium imaging, Gangluy and others (2001) investigated the
developmental timecourse of GABA-induced increases in intracellular calcium levels in
hippocampal cultures isolated from E18 rats. In hippocampal neurons allowed to remain
in culture for 4 to 9 days, increases in [Ca2+]i were observed with GABA application.
The increase in [Ca2+]i was blocked with GABAA antagonists and L-type calcium channel
blockers. These data demonstrate that GABAA receptor activation can lead to influx of
calcium through L-type calcium channels during the early neonatal period. The
facilitation of L-type calcium current could further increase calcium influx in response to
GABA in a subset of cells.
The change in chloride transporter expression decreases the internal chloride
concentration by increasing the extrusion of chloride, which results in a change of the
reversal potential of GABAA mediated current (Ben-Ari et al., 1989; Leinekugel et al.,
1995, 1997, 1998; Khazipov et al., 1997). It has been well documented that the
upregulation of KCC2 transporter levels play a role in changing the chloride reversal
potential (Payne, 1997; Lu et al., 1999; Rivera et al., 1999; Ganguly et al., 2001). Rivera
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and others (1999) demonstrated that inhibition of KCC2 expression with antisense
oligodeoxynucleotides delayed the shift in the reversal potential of GABAA responses
from depolarizing-to-hyperpolarizing in cultured neonatal rat hippocampal slices. They
demonstrated that in cultured hippocampal slices isolated from postnatal 0 to 4 day old
rats, GABAA receptor activation evoked depolarizing responses, whereas in hippocampal
slices isolated from postnatal rats 13 to 30 days old GABAA receptor activation evoked
hyperpolarizing responses. When KCC2 expression levels were inhibited with antisense
oligonucleotides in slices from postnatal 11 to 13 day old rats, the driving force of
GABAA demonstrated a significant positive shift when compared to control slices
(Rivera et al., 1999). These data demonstrate that KCC2 expression is involved in the
fast hyperpolarizing GABAA receptor responses in mature hippocampal neurons.
In addition to the upregulation of KCC2, the downregualtion of NKCC1
expression may also play a role in changing the chloride reversal potential (Plotkin et al.,
1997; Wang et al., 2002). However, there are several conflicting results when looking at
NKCC1 mRNA levels within the developing rat hippocampus. Using in situ
hybridization, Plotkin et al. (1997) reported that NKCC1 mRNA expression levels peak
in the hippocampus of rats at postnatal day 7. In comparison, Wang et al. (2002) who
also performed in situ hybridization reported higher NKCC1 mRNA levels in the
hippocampus of postnatal day 15 rats through postnatal day 40 rats. Most of the studies
on KCC2 and NKCC1 expression have measured mRNA levels. In theory, changes in
mRNA levels should lead to changes in protein. However, mature protein levels are not
only dependent on translation of mRNA, but also on the degradation of the protein. In
the current study, protein levels of KCC2 and NKCC1 were measured rather than mRNA
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levels since ultimately it is the protein that is the end product. Therefore, the
developmental changes of NKCC1 and KCC2 protein levels within the developing rat
hippocampus were further characterized.
It has been demonstrated that GABA may be responsible for the depolarizing-tohyperpolarizing switch and that calcium influx is necessary for this GABAA mediated
switch (Ganguly et al., 2001). Ganguly et al. (2001) showed that application of GABAA
antagonists delayed the excitatory to inhibitory switch and also delayed the increase in
KCC2 mRNA expression levels in cultured hippocampal neurons. In addition, chronic
blockade of L-type calcium channels with the L-type channel antagonist nimodipine
significantly delayed the developmental change in the GABAA reversal potential. These
two observations taken together suggest that GABAA receptors directly depolarize the
membrane to open L-type calcium channels and that influx of calcium is involved in the
developmental maturation. Ganguly et al. (2001) did not directly look at the effects of Ltype calcium current on KCC2 transporter protein levels. Calcium influx across L-type
calcium channels may regulate the changes in chloride transporter expression. Therefore,
the enhancement of L-type calcium current by GABAB receptor activation demonstrated
by Carter and Mynlieff (2004) may play a role in increasing intracellular calcium levels
that mediate the switch of GABAA responses from excitatory to inhibitory effects. The
goal of the present study was to increase our knowledge of GABAB receptors and their
downstream modulation to gain a better understanding of their functional role in the
development of a mature CNS.
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G-proteins
GABAB receptors are coupled to guanine nucleotide-binding proteins, also known
as G-proteins. G-proteins linked to GPCRs are heterotrimeric proteins consisting of an α,
β, and γ subunit. GPCRs belong to a family of seven transmembrane spanning receptors
and are activated by a variety of extracellular neurotransmitters and hormones. When
activated by ligands or agonists, GPCRs interact with G-proteins, which stimulate the
exchange of GDP on the Gα subunit for cytoplasmic GTP. Following nucleotide
exchange, the Gα subunit dissociates from the Gβγ subunits which remain anchored to
the plasma membrane. Both the free Gα-GTP bound subunit as well as the Gβγ subunit
complex are biologically active and can modulate downstream effector systems. The
intrinsic GTPase activity of the α subunit converts GTP to GDP + Pi, which promotes the
reassociation of the inactive Gα-GDP to the Gβγ complex (for review see McCudden et
al., 2005; Wettschureck and Offermanns, 2005).
Gα subunits are classified into four groups based on their sequence similarity and
activation of various cell signaling systems (Table 2). Each family consists of several
different types of α-subunits, some of which show very specific expression patterns (for
review see McCudden et al., 2005; Wettschureck and Offermanns, 2005). Gαs proteins
activate adenylyl cyclase and are activated by cholera toxin-mediated ADP ribosylation,
whereas the Gαi/o proteins inhibit adenylyl cyclase activity and are inhibited by pertussis
toxin (PTX) mediated ADP ribosylation (Fields and Casey, 1997). Gαt, also known as
transducin, is found in cells of the retina and is coupled to the GPCR, rhodopsin. The Gprotein that is primarily found in taste cells is called Gαgust or gustducin. Gαq/11 proteins
activate phospholipase C (PLC) and are not affected by either cholera toxin or PTX.
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Gα12/13 results in the activation of a small GTPase RhoA, which is overexpressed in
various tumor cell types (Fritz et al., 1999; Abraham et al., 2001; Kamai et al., 2001;
Fritz et al., 2002).
G-Protein
Subfamily

Gα

Location

Gα
αs

αs
αolf

Ubiquitous
Olfactory
Epithelium
Ubiquitous
Neuronal
Neuronal
Retinal Rods
Retinal Cones
Taste Buds

Gα
αi/o

Gα
αq

αi1, αi2, αi3
αo
αz
αt-r
αt-c
αgust
αq, α11
α14
α15/16
α12, α13

Gα
α12/13

Ubiquitous
Kidney, Lung
Hematopoietic
cells
Ubiquitous

Pharmacology

Potential Effector
Proteins

Cholera Toxin

Activates Adenylyl
Cyclase

Pertussis
Toxin

Inhibits Adenylyl Cyclase,
activates K+ channels,
inhibits Ca++ Channels,
increases
phosphodiesterase 6
activity (rods and cones)

Ym-254890

Activates
Phosphlipase Cβ1-4
Activates Small Gproteins, RhoA, and Heat
Shock Protein

Table 2: Pharmacology and signaling properties of the major G-protein subunit types. (Table
adapted from Wettschureck and Offermanns, 2005; Tedford and Zamponi, 2006).

Following dissociation of Gα-GTP, the Gβγ subunit can activate a large number
of effectors, including G-protein-regulated inward-rectifier K+ channels (GIRK
channels), PLCβ, and adenylyl cyclase (Camps et al., 1992; Smrcka and Sternweis, 1993;
Park et al., 1993; Pian and Dobbs, 1995; Yamada et al., 1998). Due to the several
different types of G-proteins, GPCRs, effectors, and regulatory proteins, there is a great
deal of versatility among the signal transduction mechanisms throughout the different cell
types of the body (for review see McCudden et al., 2005; Wettschureck and Offermanns,
2005).
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Neuronal calcium channels are directly regulated by both Gα and Gβγ subunits as
well as indirectly regulated by G-proteins through second messenger systems (for review
see Schultz et al., 1990; Dolphin, 1998; Wettschureck and Offermanns, 2005). N-type
and P/Q-type calcium channels are directly inhibited by Gβγ in a membrane delimited
manner (for review see Tedford and Zamponi, 2006). Gβγ subunits remain anchored to
the plasma membrane, whereas the Gα subunit can diffuse throughout the cytoplasm.
(Herlitze et al., 1996; Ikeda et al., 1996). Binding of the Gβγ subunits to the intracellular
loop between domains I and II of the α1 subunit of VDCCs makes it more difficult for the
channel to open (Bean, 1989b; Boland and Bean, 1993; Herlitze et al., 1997; Zamponi et
al., 1997; for review see Tedford and Zamponi, 2006). In addition to direct binding, Gproteins can activate second messenger systems that activate protein kinases, which can
in turn regulate calcium channel activity. Phosphorylation of the channel protein itself or
a regulatory component can either stimulate or inhibit channel activity.
The signal transduction mechanism of L-type calcium current facilitation by
GABAB receptor activation in the mammalian nervous system has not been identified and
was a main focus of my research project. GABAB receptor activation of PKC has been
shown to facilitate L-type current in salamander retinal neurons (Shen and Slaughter,
1999). PKC activation within the hippocampus has also been shown to enhance L-type
calcium current (Doerner et al., 1990; Doerner and Alger, 1992). However, this
facilitation was not linked to GABAB receptor activation. Shen and Slaughter (1999) also
demonstrated inhibition of the facilitation of L-type calcium current by GABAB receptor
activation in the salamander retina in the presence of a PKA inhibitor, but the response
was smaller than the blockade of facilitation seen with PKC inhibitors. The present

21
project directly investigated the role of PKC and PKA in GABAB receptor mediated
facilitation of L-type calcium current within the neonatal rat hippocampus using multiple
PKC and PKA inhibitors as well as activators for both PKC and PKA.

Protein Kinase C
PKC represents a family of serine/threonine protein kinases that are stimulated by
diacylglycerol (DAG), calcium, and phospholipids. The structure of PKC includes a
highly conserved catalytic domain along with a regulatory domain that keeps the kinase
in an inactive conformation (Figure 1.7; for review see Steinberg, 2008). Activation of a
Gαq family protein and certain Gβγ subunits results in the activation of PLC, which in
turn cleaves the membrane lipid phosphatidylinositol bisphosphate (PIP2) into DAG and
inositol trisphosphate (IP3). DAG stays within the membrane and activates PKC (Figure
1.8). Activated PKC can then phosphorylate target proteins, such as sodium, potassium,
and calcium channels.
DAG

Inactive
Active
PS
Calcium

Figure 1.7: PKC is a monomeric protein. Certain isoforms require Ca2+,
DAG, and phosphatidylserine (PS) for activation and relief of autoinhibition.

There are at least 12 different isoforms of PKC, which are classified into three
classes based on their activation requirements (Tanaka and Nishizuka, 1994; Nishizuka,
1995; Webb et al., 2000; Zarate and Manji, 2009). The conventional PKC isoforms are
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Figure 1.8: PKC pathway. PLC can be activated by the Gq family of Gα
subunits as well as certain Gβγ subunits. The activated phospholipase cleaves
PIP2 into IP3 (inositol trisphoshpate) and DAG. IP3 initiates intracellular calcium
release from the endoplasmic reticulum, which induces the translocation of PKC
to the plasma membrane. PKC is activated by the combination of DAG, calcium,
and phospholipids. Once activated, PKC is able to phosphorylate target proteins.

α, βI, βII, and γ. These isoforms require calcium and DAG for activation. There are five
novel PKC isoforms, δ, ε, η, θ, and µ. The novel PKC isoforms do not require calcium
for activation, but do require DAG for activation. Lastly, the atypical PKC isoforms, ζ, λ,
and ι, require neither calcium nor DAG for activation (Tanaka and Nishizuka, 1994;
Webb et al., 2000; Zarate and Manji, 2009). In addition to differences in their mode of
activation, the different isoforms of PKC also vary in their structure, subcellular
localization, and tissue specificity. Multiple PKC isoforms can exist within a single cell,
but the subcellular localization may differ for each isoform. Thus, each isoform may be
involved in regulating different cell functions throughout various regions of the cell
(Roisin and Barbin, 1997).
Subfamilies of
PKC

Isoforms

Conventional

α, βI, βII, γ

Novel

δ, ε, η, θ, µ

Atypical

ζ, ι, λ

Activation
Requirements
Ca2+, DAG,
Phospholipid
DAG and
Phospholipid
Phospholipid

Table 3: PKC isoforms are divided
into three subfamilies based on their
mode of activation.
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All known PKC isoforms have been shown to be expressed in the mammalian
CNS (Tanaka and Nishizuka, 1994). However, all of the PKC isoforms have a very
specific tissue distribution at different developmental time points in the CNS (Oehrlein et
al., 1998). PKC is present in high concentrations in hippocampal neurons and plays a
large role in many developmental processes, such as neuronal differentiation (Webb et
al., 2000). Various PKC isoforms are present in hippocampal neurons at different
developmental stages. A study by Roisin and Barbin (1997) looked at the presence of
several different PKC isoforms (α, β, ε, γ, and ζ) in hippocampal cultures isolated from
embryonic rats as well as in hippocampal protein extracts isolated from postnatal rat pups
of varying ages using Western blot analysis (Figure 1.9). When analyzing protein
content at specific ages, PKC α (∆) is expressed at low levels until postnatal day 4 where
it begins to rise (Figure 1.9A). In comparison, PKC γ (▲) is barely detectable until
postnatal day 14. PKC ε (●) is detectable in the hippocampal preparations isolated from
embryonic rats with protein levels peaking during the first postnatal week. PKC β (○)
levels are low in embryonic tissue, but begin to rise starting postnatal day 0. There were
two immunoreactive bands for PKC ζ (75 kDa and 83 kDa), which demonstrate different
expression patterns throughout development (Figure 1.9B). The 75 kDa band (■) is more
highly expressed in the embryonic hippocampus and is not highly expressed past the
second postnatal week, whereas the 83 kDa band (□) protein levels peak after the first
postnatal week (Roisin and Barbin, 1997). This is one of the few studies to explore the
presence of the different PKC isoforms within hippocampal neurons during development.
Since this study is well over ten years old, not all of the PKC isoforms were investigated.
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Figure 1.9: PKC isoforms vary throughout hippocampal development. Quantitative analysis by
Western blot of PKC isoform expression in hippocampal protein extracts from rats of varying
ages. (A) For PKC α, β, γ, and ε isoforms, data are expressed as the percentage of the value
measured in the adult hippocampus. (B) For PKC ζ two bands were immunodetected. Each
value is the mean of three determinations. Adapted from Neurochemistry International. Vol. 30,
No. 3, Roisin MP, Barbin G, Differential expression of PKC isoforms in hippocampal neuronal
cultures: Modifications after basic FGF treatment, 261-270, 1997, with permission from Elsevier.
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Very few investigators have studied L-type calcium channel modulation by PKC
and the studies that have been published demonstrate several conflicting results. There
are many factors involved in determining whether phosphorylation of L-type calcium
channels by PKC can either result in an increase or a decrease of calcium current. These
include the type of cell, the type of calcium channel present, the type of accessory
proteins associated with the calcium channels, as well as the specific isoform of PKC that
is activated. PKC activation enhances L-type calcium current in cardiac myocytes, but
CaMKII has also been shown to be involved in the signaling pathway (O-Uchi et al.,
2008). When Cav1.3 channels were heterologously expressed in HEK cells, PKC
activation with phorbol esters decreased whole-cell Cav1.3 current (Baroudi et al., 2006).
Using single-channel recording, it was demonstrated that PKC activation reduced Cav1.3
current open probability, by decreasing open time and increased closed time (Chahine et
al., 2007). Studies comparing the peak and sustained component of whole-cell currents
in dorsal root ganglion cells from fetal mice in response to PKC activation, demonstrated
a decrease in N-type calcium current with no effect on L-type calcium current (Gross and
MacDonald, 1989). Each of these studies demonstrate a different response to PKC
activation, either an increase, no change, or a decrease in L-type calcium current. These
demonstrate the complexity of the signaling pathways involved in the regulation of
calcium channels and the various factors that can affect the response to PKC activation.
PKC has also been shown to modulate the other HVA calcium channel types, Ntype, P/Q-type and R-type calcium channels. When heterologously expressed in HEK
cells, phosphorylation of both N-type and P/Q-type calcium channels by PKC increased
the activity of the channels and also decreased the amount of inhibition of the channels
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by Gβγ (Swartz, 1993; Zamponi et al., 1997; Herlitze et al., 2001). In Xenopus laevis
oocytes, PKC activation enhanced both heterologously expressed N-type and R-type
calcium currents, but did not affect either P/Q-type or L-type Cav1.2 calcium current
(Stea et al., 1995). Stea et al., (1999) also determined that the enhancement of N-type
and R-type calcium current was dependent on the coexpression of a β subunit. In
comparison, other studies have shown that PKC activation can decrease N-type calcium
current in the dorsal root ganglia of chick embryos through activation of α2-adrenergic
receptors by norepinephrine (Diversé-Pierlussi et al., 1993, 1995). In these cells N-type
calcium current inhibition by activation of GABAB receptors with GABA is not
dependent on PKC (Diversé-Pierlussi et al., 1993, 1995). PKC inhibitors had no effect
on the GABA induced inhibition of N-type current in dorsal root ganglion cells. Using
guinea pig hippocampus, Doerner et al. (1990) demonstrated N-type calcium current
inhibition in response to direct activation of PKC in pyramidal cells, but they did not look
for any effects in interneurons. Although expression of calcium channels in heterologous
systems has provided a wealth of information about the characteristics of calcium
channels and signaling mechanisms involved in their regulation, these mechanisms may
be different to what is seen in native tissues.

Protein Kinase A
Many cellular functions involve the second messenger cyclic adenosine 3’,5’monophosphate (cAMP), whose concentration is modulated by adenylyl cyclase and
phosphodiesterase (PDE) activity. Increased cAMP levels within neurons activates
cAMP-dependent kinase or PKA, which phosphorylates target proteins. When in its
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inactive form, PKA is a tetrameric structure consisting of two regulatory subunits along
with two catalytic domains (Figure 1.10). There are four different regulatory subunits
(RIα, RIβ, RIIα, RIIβ) and three catalytic subunits (Cα, Cβ, Cγ; for review see
McKnight et al., 1988; Doskeland et al., 1993; Brandon et al., 1997). Each regulatory
subunit contains two cAMP binding sites (Taylor et al., 1990). Following binding of
cAMP to the regulatory subunit, a conformational change occurs that results in the
dissociation of the catalytic subunits. Once released from the regulatory subunits, these
monomeric catalytic subunits are now active and able to phosphorylate serine and
threonine residues on downstream target proteins.

Inactive PKA

C

Active PKA

C

C

R R

C

+

+
cAMP

R R

Figure 1.10: The structure of PKA consists of two regulatory subunits (R) and two
catalytic subunits (C). In the absence of cAMP, the catalytic subunits associate with
the regulatory subunits. As a result of cAMP binding, a conformational change in the
regulatory subunit releases the catalytic subunits. The active catalytic subunits are
free to phosphorylate proteins.

Adenylyl cyclase is an enzyme that synthesizes cAMP from adenosine-5'triphosphate (ATP). Adenylyl cyclase activity can be either stimulated by Gαs resulting
in an increase in cAMP levels or inhibited by Gαi resulting in decreased cAMP levels.
cAMP levels are also controlled by PDE, an enzyme that breaks down cAMP. PKA
regulates several functions within different cell types, including cellular metabolism,
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changes in gene expression, cell and tissue development, neuronal excitability, ion
channel conductivity, and changes in synaptic plasticity (for review see Brandon et al.,
1997; Nguyen and Woo, 2003).

Phosphorylation of L-type calcium channels by

PKA often leads to the enhancement of intracellular Ca2+ concentration. For example in
skeletal muscle, Cav1.1 L-type calcium current is enhanced through PKA
phosphorylation of a single serine residue (Ser 1982) in the C-terminus of the α1 subunit
(De Jongh et al., 1996). This enhancement in intracellular Ca2+ levels ultimately
increases the force of the contraction (Schmid et al., 1985; Arreola et al., 1987;
Sculptoreanu et al., 1993a). Within the heart, β-adrenergic receptor activation leads to
the enhancement of L-type calcium current through phosphorylation by PKA (for review
see Kamp and Hell, 2000). Direct PKA activation by 8-Br-cAMP increases both the
mean channel open time and probability of Cav1.2 L-type calcium channels in cultured
rat cardiac myocytes (Reuter et al., 1982; Cachelin et al., 1983). Therefore, it is possible
that PKA is involved in the signaling pathway of L-type calcium current by GABAB
receptors in the neonatal rat hippocampus.

The overall goal of this research project was to continue exploring the novel
phenomenon of L-type calcium current facilitation by GABAB receptor activation within
the neonatal rat hippocampus. The first set of experiments investigated the
developmental time course of L-type current facilitation by GABAB receptor activation in
the first two developmental weeks to determine at which age facilitation was most
prominent. Since many other investigators use either embryonic or adult hippocampal
tissue for their studies rather than neonatal tissue, the facilitation of L-type calcium
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current by GABAB receptor activation had not been previously demonstrated. The
GABAergic system is not yet fully developed in embryonic hippocampal tissue and
hippocampal cultures isolated from embryonic rats contain mostly excitatory pyramidal
cells (Banker and Cowan, 1979; Scholz and Miller, 1991). Only 5-10% of neurons
demonstrate GABA immunoreactivity in hippocampal cultures isolated from E17 rats,
which is consistent with the excitatory synaptic potentials predominately observed in E17
embryonic cultures (Scholz and Miller, 1991). A greater percentage (12-36%) of neurons
express GABA in cultures isolated from E18 rats (Scholz and Miller, 1991). Since there
are very few GABAergic neurons in cultures isolated from early embryonic hippocampi,
it could explain why facilitation of L-type calcium current has not been observed.
Although the GABAergic system is fully developed in brain slices, it is problematic
looking at receptor mediated effects on current in slices because the cells have many
processes making it difficult to control the voltage. In acutely dissociated adult
hippocampal damage occurs to surface proteins by either physical damage or trypsin
mediated digestion and thus acute isolations are not an ideal preparation for these types of
experiments. Hippocampal neurons isolated from adult tissue will not survive overnight
in culture, whereas hippocampal neurons isolated from neonatal tissue will survive
overnight in culture. Waiting overnight allows enough time for the neurons to recover
from dissociation and for the reinsertion of channels or receptors. In addition, functional
effects are likely to differ greatly in neonate versus adult due to major changes in the
GABAergic system during the early neonatal period. Since facilitation has only been
observed in neonatal cultures, it is possible that L-type calcium current facilitation could
be involved in a developmentally regulated process.
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Secondly, the role that L-type calcium current facilitation played in the regulation
of chloride transporters during the maturation process of the GABAergic system was
investigated. Due to the different subcellular distribution of N-type and L-type calcium
channels on neurons in vivo, L-type channels are not generally linked to the regulation of
neurotransmitter release. Rather activation of L-type calcium channels, which are
localized on the cell body and dendritic region of neurons, can lead to a number of
cellular effects ranging from gene activation to changes in postsynaptic activity
(Westenbroek et al., 1990; Bading et al., 1993; Budde et al., 1998). It is possible that
GABAB receptor mediated facilitation of L-type calcium current during the first few
weeks of development may play a role in the regulation of chloride transporters that are
necessary for the maturation of the GABAergic response in neurons.
Lastly, the signal transduction pathway of GABAB receptor modulation of L-type
calcium channels in hippocampal neurons was explored using several kinase inhibitors as
well as kinase activators. Since L-type calcium channels have several consensus sites for
phosphorylation by kinases, the involvement of both PKC and PKA in the signaling
pathway was investigated. Both PKC and PKA have been implicated in the signal
transduction pathway of GABAB receptor facilitation of L-type calcium current in
salamander retinal cells (Shen and Slaughter, 1999). Therefore, it is likely that PKC and
PKA may be involved in the facilitation of L-type calcium current by GABAB receptor
activation within the neonatal rat hippocampus.
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CHAPTER 2
MATERIALS AND METHODS
Isolation of Hippocampal Neurons
All animal protocols were approved by the Marquette University Institutional
Animal Care and Use Committee and followed the guidelines set forth by the U.S. Public
Health Service. Neurons were isolated by a technique developed for the hippocampus of
postnatal rats as published previously (Mynlieff, 1997). Sprague-Dawley rat pups of
varying ages were anesthetized with CO2 and sacrificed by decapitation. The head was
immersed in 70% ethanol for 3 minutes for decontamination and rinsed in sterile rodent
Ringer’s solution with glucose (146 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2,
10 mM HEPES, 11 mM D-glucose, pH 7.4 with NaOH). The hippocampi were dissected
from the brain in oxygenated, cold (~5°C), sterile rodent Ringer’s solution with glucose
using sterile technique. For electrophysiology experiments, dissections were restricted to
the superior region of the hippocampus (excluding the dentate gyrus). For protein
analysis of transporters, the entire hippocampus was used for cultures. The tissue was
placed in PIPES-buffered saline (120 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2,
25 mM D-glucose, 20 mM piperazine-N,N’-bis[2-ethanesulfonic acid], pH 7.0 with
NaOH) and sliced into ~1 mm3 sections. The tissue was transferred into a small vial and
incubated at room temperature in 1 ml of 0.5% Trypsin XI and 0.01% DNase I (SigmaAldrich, St. Louis, MO) in PIPES buffered saline at room temperature for 20-30 minutes
with 100% oxygen blown over the tissue. This incubation was followed by another
incubation for 40-60 minutes depending on the age of the pup at 35°C under continuous
oxygen. The tissue was rinsed with 1 ml trypsin inhibitor solution (1 mg/ml trypsin
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inhibitor, Type II-O: chicken egg white (Sigma-Aldrich, St. Louis, MO) and 1 mg/ml
bovine serum albumin) in rodent Ringer’s solution and rinsed again with 1 ml
Neurobasal-A growth medium fortified with B27 supplement (Invitrogen, Carlsbad, CA),
0.5 mM glutamine, and 0.02 mg/ml gentamicin. The tissue was triturated with a firepolished Pasteur pipette in fresh growth medium and plated onto the center of poly-Llysine coated dishes for both electrophysiology and protein analysis. The culture dishes
were coated with 1mg/ml of poly-L-lysine (MW 38,500 to 60,000, Sigma-Aldrich, St.
Louis, MO) dissolved in 0.15 M boric acid (pH of 8.4 with NaOH). A detailed protocol
for making poly-L-lysine dishes can be found in Mynlieff (1997). Cells were allowed to
settle to the bottom of the dish for 5 minutes prior to the addition of growth medium to
bring the volume up to 2 ml per dish. Neurons were incubated at 37°C in a 5% CO2
water-jacketed incubator.
There are many advantages to using cultured cells for electrophysiological
studies. Cultured cells have very few processes which allows for proper control over
voltage and prevents space clamp issues when performing patch clamp recordings. In
addition, it is possible to apply compounds directly to an individual cell without
contaminating other cells within the culture by using a U-tube system (Mynlieff, 1997).
Cultured cells provide much more stable recordings compared to acutely isolated
hippocampal cells. Waiting 20 - 24 hours after dissociation allows time for the
reinsertion of channels and receptors after the processes have been sheared off. For
example, N-type and P/Q-type calcium channels, which are primarily found on processes,
are reinserted into the cell body of the neuron (Figure 2.1; courtesy of Katie Halstead, a
former undergraduate). Therefore, it is possible to study the modulation of channels
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normally found in the synapse on the soma. Hippocampal cultured neurons isolated in
the Mynlieff laboratory retain their electrophysiological properties and firing properties
after dissociation (Mynlieff, 1997, 1999).

Control

CaV1.2 (L-type)

CaV2.1 (P-type)

CaV1.3 (L-type)

CaV2.2 (N-type)

CaV2.3 (R-type)

Figure 2.1: Reinsertion of HVA calcium channels. To determine the presence
of different HVA calcium channel types, hippocampal cultures isolated from
postnatal rats 6 to 9 days old were labeled with primary antibodies against the α1
calcium channel subunits 24 hours following dissociation. All cultures treated
with antibodies 24 hours after dissociation displayed staining for all of the α1
subunits tested, suggesting that 24 hours is sufficient time for the reinsertion and
stabilization of calcium channels in the membrane. Approximately only 20% of
the cells stained darkly for the CaV1.2 (L-type) calcium channel, while almost
100% of the cells stained uniformly and intensely with the CaV1.3 (L-type)
calcium channel. Data was obtained by Katie Halstead.
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Hippocampal cultures isolated from embryonic rat pups are predominantly
comprised of excitatory pyramidal cells, and thus are not ideal for the study of
hippocampal interneurons (Banker and Cowan, 1979; Scholz and Miller, 1991). One of
the benefits of using postnatal rat hippocampal cultures is that they are highly enriched in
interneurons, making them an ideal system for studying the effects of GABAB receptor
modulation of calcium channels during development. When cultures isolated from a 7
day old postnatal rat were labeled with anti-GABA antibodies, 41.8 ± 5.0% of the
neurons contained GABA suggesting that almost 50% of the cells in the culture were
GABAergic inhibitory interneurons (Mynlieff, 1997). One of the disadvantages to using
cultured neurons is that the superior region of the hippocampus (CA1 and CA3) contains
pyramidal cells along with several different types of inhibitory interneurons. After such a
short time in culture it is not possible to identify the cells based on morphology
(Mynlieff, 1997).

Electrophysiology
Whole cell patch clamp recording was used to measure calcium currents in
voltage clamp mode. Data were collected using a Dagan 3900A patch clamp amplifier
(Dagan Corporation, Minneapolis, MN) combined with a Digidata 1322 data acquisition
system and a computer with pCLAMP 9.0 software (Molecular Devices, Sunnyvale, CA).
All electrophysiological experiments were performed at room temperature 20-24 hours
following dissociation. Although voltage control is best immediately following
dissociation, it was necessary to wait overnight to allow the cells time to recover from
enzymatic dissociation and adhere to the bottom of the dish (Mynlieff, 1997). Recording
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electrodes (3-7 MΩ) were made from borosilicate glass capillaries on a Flaming/Brown
Micropipette Puller model P-87 (Sutter Instrument Co., Novato, CA). The internal
solution used to fill the patch electrodes contained 140 mM Cs-aspartate, 5 mM MgCl2,
10 mM Cs2EGTA, 10 mM HEPES, 2 mM ATP-Na2, and 0.1 mM GTP (pH of 7.4 with
CsOH and osmolarity between 310-320 mOsm). The external solution used for calcium
current measurements contained 10 mM CaCl2, 145 mM TEACl, 10 mM HEPES and 1
µM tetrodotoxin (Sigma-Aldrich, St. Louis, MO) to block Na+ currents (pH of 7.4 with
CsOH and osmolarity between 300-310 mOsm). Whole cell currents were electronically
filtered at 1 kHz and digitized at 2 kHz. Linear components of leak current were
subtracted post-hoc by the passive resistance protocol in pClamp 9.0.
For the majority of the electrophysiology experiments, the sustained component
of the calcium current was used versus the peak component of the calcium current
(Figure 2.2). The peak current is a combination of several different types of calcium
current, which can hamper the interpretation of these data. Since L-type calcium
channels exhibit slow inactivation kinetics, the sustained current component at the end of
the 300 msec depolarization pulse to +10 mV was measured to minimize the contribution
of T-type, N-type, P/Q-type, and R-type calcium current while maximizing the
contribution of L-type calcium current to the total measurement. The inactivation rate for
L-type calcium current is very slow (τ > 500 msec), whereas the inactivation rates for Ntype, P/Q-type, and R-type calcium current is fast (τ ≈ 50-80 msec; Tsien et al., 1988).
There may still be contributions of the other current types at the end of the 300 msec
pulse, but the majority of the sustained current should be primarily comprised of L-type
current due to its slower inactivation kinetics when compared to the other HVA calcium
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current types. Previous studies in which nimodipine, an L-type calcium channel
antagonist, blocked the ability of baclofen to facilitate sustained current have confirmed
that the facilitatory effect of GABAB receptor activation on calcium currents was entirely

PEAK CURRENT

SUSTAIEND CURRENT

mediated through L-type channels (Carter and Mynlieff, 2004).

Figure 2.2: Peak versus sustained current.
Calcium currents were elicited by a 300
msec depolarization to +10 mV from a
holding potential of -80 mV. The peak
current is measured at the beginning of the
300 msec pulse, while the sustained current
is measured at the end of the 300 msec
pulse.

+ 10 mV
- 80 mV

Drugs and Enzymes Used in Electrophysiology Experiments
Multiple kinase inhibitors with different chemical structures as well as specific
kinase activators were used for verification of results on whether PKC and/or PKA are
involved in the signal transduction pathway of L-type calcium current facilitation by
GABAB receptor activation. At certain concentrations kinase inhibitors can lose their
specificity for a particular kinase, therefore the concentrations used for each compound
were carefully chosen. Experimental concentrations were determined by examining the
literature as well as comparisons with the IC50 / EC50 (Table 4). If a compound interacted
with a single kinase a higher concentration could be used, whereas lower concentrations
were necessary for compounds that were less specific for a particular kinase and may
interact with other kinases at higher concentrations.
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Compound

Action

PKC fragment 19-36
GF-109203 X
Chelerythrine Chlroide
Phorbol Ester (PMA)
H-89 dihydrochloride hydrate
Rp-cAMPS
8-BR- cAMP

inhibits PKC
inhibits PKC
inhibits PKC
activates PKC
inhibits PKA
inhibits PKA
activates PKA

Concentration
Used
2 µM
500 nM
5 µM
1 µM
1 µM
30 µM
500 µM

IC50 / EC50
147 nM
10 nM
0.66 µM
1 nM
48 nM
11 µM
166 µM

Table 4: Kinase activators and inhibitors for PKC and PKA. The above compounds were used to
investigate the signal transduction mechanism of L-type calcium current facilitation by GABAB
receptor activation.

(RS)-baclofen (Tocris, Ellisville, MO) and 8-Bromoadenosine 3´, 5´- cyclic
monophosphate (8-Br-cAMP, Sigma-Aldrich, St. Louis, MO) were directly dissolved in
the external calcium solution. GF-109203X (AG Scientific, INC., San Diego, CA) and
phorbol-12-myristate-13-acetate (PMA, Calbiochem, La Jolla, CA) were dissolved in
dimethyl sulfoxide (DMSO) at 1000 - 5000 fold the final concentration. Rp-cAMPS
triethylammonium salt hydrate, H-89 dihydrochloride hydrate, and chelerythrine chloride
(Sigma-Aldrich, St. Louis, MO) were dissolved in water at 333 – 10,000 fold the final
concentration. All concentrated stock solutions of the drugs were stored at -20°C until
use up to two months. These compounds were diluted to their final concentration in the
external calcium solution on the day of use. The drugs dissolved in the external calcium
solution were applied to cells using a U-tube delivery system, constructed with PE-10
polyethylene tubing housed in a piece of glass tubing, which allowed for quick
application and washout of compounds that were gravity fed onto the cell and removed
by vacuum suction. A blue dye, Fast Green FCF (Sigma-Aldrich, St. Louis, MO), was
added to the drug solution to visualize application of the drug onto the cell and to ensure
complete washout of the drug off the cell. Protein kinase C fragment 19-36 (SigmaAldrich, St. Louis, MO) was dissolved in 1% acetic acid and included in the internal
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solution with less than a 0.1 change on the pH of the internal solution. Pertussis toxin
(PTX, Sigma-Aldrich, St. Louis, MO) was dissolved in distilled water at 500 fold the
final concentration with bovine serum albumin (4 mg/ml) added for stabilization.
Cultures were exposed to 200 ng/ml PTX for a minimum of 16 hours starting two hours
after dissociation. A longer exposure time is necessary with PTX treatment, to ensure
complete inhibition of Gi/o proteins. This concentration and time of pre-treatment is
similar to the concentration (250 ng/ml) and time of PTX exposure (26 hrs) that Scholz
and Miller (1991) used to demonstrate the effect of baclofen on calcium currents in
hippocampal cell cultures. Higher concentrations as well as a longer PTX exposure time
would be necessary for complete inhibition of Gi/o proteins if hippocampal slices were
being used for electrophysiological experiments.

Electrophysiology Data Analysis and Statistics
To analyze electrophysiological data, the magnitudes of the currents in response
to a +10 mV depolarizing pulse were plotted as a scatter graph vs. time. The linear
regression and 95% confidence intervals were determined for the control current data
points and were used to determine the effect of 10 µM baclofen application on calcium
current amplitude as described in Carter and Mynlieff (2004). Multiple control currents
were measured before and after drug application. This allowed for compensation due to
run-up or run-down of calcium currents (Figure 2.3). The percent change with baclofen
application was determined by comparison to the regression line. The cells were grouped
according to whether baclofen application caused a deviation in the magnitude of the
calcium current when compared to the linear regression line determined by the control
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data. The change in current magnitude was considered significant if it fell outside of the
95% confidence interval for the regression line. If the current with baclofen application
fell above the 95% confidence interval the cells were grouped as demonstrating an
increase in current and if it fell below the cells were grouped as demonstrating a decrease
in current. In cells where the current with baclofen application fell within the 95%
confidence interval, the cells were grouped together as demonstrating no change.
B.

A.
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Figure 2.3: Analysis of calcium currents. Calcium currents were elicited by a 300 msec
depolarization to +10 mV from a holding potential of -80 mV. These data represent sustained
calcium currents recorded from cultured hippocampal neurons isolated from 7 day old rats. The
linear regression (solid line) and 95% confidence interval (dashed line) were determined for the
control currents (●). The percent change with 10 µM baclofen application (▲) was determined by
comparison to the regression line. In all cells where the current with baclofen fell within the 95%
confidence interval the effect was counted as “no change”.

In experiments where kinase inhibitors or kinase activators were used, a
contingency table was set up as a 2X3 table where row 1 and row 2 contained control
cells and cells treated with a particular compound. The three columns contained the
number of cells in each row demonstrating an increase, no change, or a decrease in
sustained calcium current in the presence of baclofen. A chi-square was used to
determine whether the columns in the contingency table vary from row to row. A Fisher
exact test was used for pairwise comparisons. To determine whether the number of cells
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that demonstrated an increase in calcium current with baclofen application in the absence
and presence of a drug was significantly different, the number of cells that demonstrated
no change or a decrease in calcium current with baclofen application were grouped
together making the pair-wise comparison between the cells demonstrating an increase
and “other” (cells demonstrating a decrease plus cells demonstrating no change). The
opposite was done to determine whether the number of cells that demonstrated a decrease
in calcium current with baclofen application in the absence and presence of a drug was
significantly different. For this case the number of cells that demonstrated no change or
an increase in calcium current with baclofen application were grouped together making
the pair-wise comparison between the cells demonstrating a decrease and “other” (cells
demonstrating an increase plus cells demonstrating no change). Averaged data are
always given as mean ± standard error of the mean (S.E.M.).

Western Blot Analysis
For Western blot analysis, whole hippocampal tissue was obtained from rats
ranging from 1 to 42 days old (D1 to D42) and from hippocampal cultures that were
obtained from postnatal day 0 rats and kept in culture for 1 to 15 days (C0-1 to C0-15).
A total volume of 2 ml of medium was maintained for cultures that were used for protein
analysis of transporters. Twenty four hours after plating the cells, 1 ml of growth
medium was removed and fresh medium was added to the dish. A volume control dish
containing 2 ml of growth medium was placed in the incubator and the appropriate
amount of fresh medium was added every other day to maintain the correct volume. For
cultures treated with drugs, 2 µl of stock solutions of either 5 mM nimodipine (Sigma-
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Aldrich, St. Louis, MO) dissolved in 5 M HCl or 10 mM (RS)-baclofen (Tocris,
Ellisville, MO) dissolved in methanol, were added daily for a total of seven days to
maintain concentrations of 5 µM or 10 µM, respectively. In addition, a few cultures were
also treated with 2-hydroxysaclofen (Tocris, Ellisville, MO), a GABAB antagonist. The
2-OH-saclofen was dissolved in 1 M NaOH to give a 10 mM stock solution. To maintain
a 10 µM concentration, 2 µl of the 2-OH-saclofen stock solution was added daily for a
total of seven days. Chloride transporter levels were also tested in cultures treated with
drug vehicles alone (methanol, HCl, and NaOH). No significant differences were found
in transporter expression levels in comparison to the control cultures (Courtesy of Eddie
Brotkowski).
Proteins were extracted by homogenization in an ice-cold sucrose buffer (250 mM
sucrose, 10 mM Tris, 10 mM HEPES, 1 mM EDTA, pH 7.2) with fresh protease
inhibitors (1 µg/ml pepstatin, 1 µg/ml leupeptin, 0.5 mg/ml pefabloc; Sigma-Aldrich, St.
Louis, MO) followed by centrifugation at 3622 x g for 10 minutes at 4°C. The
supernatant was centrifuged at 39,104 x g for 30 minutes at 4°C. The final pellet was
resuspended in homogenizing buffer and stored at -80°C for less than 6 months. Protein
concentration was measured with an enhanced BCA protein assay (Pierce, Rockford, IL).
NuPAGE lithium dodecyl sulfate (LDS) sample buffer and sample reducing agent
(Invitrogen, Carlsbad, CA) were added to the membrane extracts and heated at 37°C for
30 minutes. The membrane extracts were run on a 3-8% Tris-acetate Novex Minigel and
transferred to a polyvinylidene difluoride (PVDF) membrane (pore size 0.45 µm) for
KCC2 experiments and a nitrocellulose membrane (pore size 0.45 µm) for NKCC1
experiments in NuPAGE transfer buffer (Invitrogen, Carlsbad, CA). The membranes
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were washed with phosphate buffered saline (PBS, 134.4 mM NaCl, 4.36 mM KCl, 10.56
mM Na2HPO4, 1.66 mM NaH2PO4 and pH to 7.4 with HCl) and blocked for 1 hour in
PBS containing 0.05% Tween, 5% nonfat dry milk, and 0.1% bovine serum albumin at
room temperature. The membranes were decorated with primary antibodies in the PBS
blocking solution against KCC2 (1:1000; Upstate Technologies, New York, NY) or
NKCC1 (1:2000; Developmental Studies Hybridoma Bank, University of Iowa, Iowa
City, IA) overnight at 4°C. Following a 1 hour wash in PBS, the membranes were
incubated with either a goat anti-rabbit or goat anti-mouse HRP-conjugated secondary
antibody (1:1000; Pierce, Rockford, IL) in the PBS blocking solution for 2 hours at room
temperature. The SuperSignal West Dura Extended Duration chemiluminescent
enhancement kit (Pierce, Rockford, IL) was used to visualize the protein bands with
classic blue autoradiography film (Molecular Technologies, St. Louis, MO).

Quantification of Western Blots
To quantify protein on Western blots, the background intensity was first
subtracted using ImageJ software (developed at U.S. National Institutes of Health and
available at http://rsb.info.nih.gov/ij/). The integrated optical density (IOD) for each
band was determined using Labworks 4.6 imaging and analysis software (UVP, Inc.,
Upland, CA). To control for gel loading, the IOD for each protein was divided by the
IOD of a band in the same lane labeled with either anti-β-actin antibodies (1:1000; Cell
Signaling Technologies, Danvers, MA) or anti-β-tubulin antibodies (1:5000; SigmaAldrich, St. Louis, MO). Multiple protein samples were analyzed per developmental
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time point studied for both whole hippocampal protein extracts and cultured hippocampal
protein extracts. Averaged data are always given as mean ± S.E.M.
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CHAPTER 3

The developmental time course of L-type calcium current
facilitation by GABAB receptor activation within
the rat hippocampus
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INTRODUCTION
The maturation and role of GABAA receptors early in neonatal development has
been extensively studied. In comparison, there is considerably less known about the
developmental changes of GABAB receptors. The current study was designed to enhance
our knowledge of GABAB receptor function during development. Previous
electrophysiological experiments in the lab performed on hippocampal neurons
dissociated from the superior region of 5 to 7 day old rat pups have demonstrated both an
inhibition and facilitation of calcium current in response to GABAB receptor activation
(Carter and Mynlieff, 2004). Using specific calcium channel blockers Carter and
Mynlieff (2004) confirmed that attenuation of calcium current was through N-type
calcium channels while facilitation was through L-type calcium channels. GABAB
receptor facilitation of HVA calcium current has been shown in a number of cell types,
including salamander retinal neurons (Shen and Slaughter, 1999), adrenal chomaffin cell
cultures (Parramόn et al., 1995), and rat dorsal root ganglion (Fujikawa et al., 1997). In
both salamander retinal neurons and adrenal chromaffin cell cultures, the facilitation of
calcium current was blocked by DHPs, demonstrating that the effect was entirely through
L-type calcium channels. The type of HVA calcium current involved in the facilitation
by baclofen in dorsal root ganglion was not investigated (Fujikawa et al., 1997).
Calcium is one of the most important intracellular messengers within neurons.
Calcium influx through VDCCs is not only important in processes of mature neurons, but
it also plays a crucial role in many developmental processes. Calcium influx is involved
in neuronal differentiation, growth, and maturation of developing neurons. Interestingly,
during the early developmental period neuronal GABAergic synaptic transmission is
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excitatory and switches to inhibitory within the first few postnatal weeks of development
(Ben-Ari et al., 1989; Owens et al., 1999). The excitatory GABAergic potential can
activate VDCCs, specifically L-type calcium channels, which results in an elevation of
intracellular calcium concentrations (Yuste and Katz, 1991; Leinekugel et al., 1995;
Khazipov et al., 1997). In turn the elevated intracellular calcium concentration can
induce an increase in brain-derived neurotrophic factor (BDNF) levels, promote neuronal
survival and differentiation, and may be necessary to form and strengthen synaptic
connections (Berninger et al., 1995; Ikeda et al., 1997; Kirsch and Betz, 1998; Kneussel
and Betz, 2000). Thus, it is possible that enhancement of L-type calcium current by
GABAB receptor activation plays an important role during the first two postnatal weeks
in hippocampal development.
There have only been a few studies to demonstrate facilitation of L-type calcium
current by GABAB receptor activation (Parramόn et al., 1995; Shen and Slaughter, 1999;
Carter and Mynlieff, 2004). Since this phenomenon has only been demonstrated in
hippocampal tissue isolated from neonatal rats 5 to 7 days old, it may only be present at a
specific time point in development. The developmental time course of L-type calcium
current facilitation by GABAB receptor activation was determined using whole-cell patch
clamp experiments on hippocampal cultures dissociated from neonatal rats of varying
ages. Neurons from the superior region of the hippocampus were isolated by a technique
that has been well established in our laboratory (Mynlieff, 1997). Hippocampal cultures
prepared in our laboratory contain excitatory pyramidal cells along with several different
types of inhibitory interneurons. To decrease the heterogeneity of the cell cultures, only
the superior region of the hippocampus containing the CA3 and CA1 regions was used.
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These types of experiments are very difficult to perform using brain slices due to space
clamp issues. Since cultured cells are spherical for the first 24 hours in culture and do not
contain many processes, one has better control over the currents and the environment of
the cell. The patch clamp technique allows for detailed analysis of ion currents and
individual cell modulation. For the present study, electrophysiological experiments with
the GABAB agonist baclofen were performed on cultured hippocampal neurons obtained
from different aged rats to identify the timecourse of L-type calcium current facilitation
by GABAB receptor activation. To determine if the varying baclofen responses observed
at different developmental time points were due to changes in the number and type of
calcium channels present, the density of HVA and LVA calcium current was measured in
cultures obtained from different aged pups.
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RESULTS
Calcium Currents in Cultured Hippocampal Neurons
Families of calcium currents were initially recorded in experiments to characterize
the baclofen responses in hippocampal cultures isolated from neonatal rats. Families of
calcium currents were elicited from a holding potential of -80 mV by 300 msec
depolarizing test steps between -50 mV and +50 mV in 10 mV increments (Figure 3.1).
Due to the heterogeneity of our cell cultures, each cell contains a different complement of
calcium channels. Therefore, there can be a wide range of activation voltages seen in
different cells. These values are also affected by the concentration and identity of the
charge carrier used (Ba2+ and Ca2+). Using 10 mM Ca2+ as the charge carrier gave
currents that generally activated between -30 mV and -10 mV depending on the presence
of T-type calcium channels (Figure 3.1). The current-voltage relationship shown in
figure 3.1B shows that from a holding potential of -80 mV, the current turns on positively
to the -10 mV test step and peaks at +20 mV. T-type calcium currents are activated at
low voltages and inactivate very rapidly as can be seen in the family of currents
represented in figure 3.1C. The current-voltage relationship shown in figure 3.1D shows
that from a holding potential of -80 mV, this cell appears to have two activation voltages.
The LVA current turns on around -40 mV with the HVA component appearing around 10 mV. The early activation voltage is due to the presence of T-type calcium current in
this cell. In contrast to the cell represented in figure 3.1 C and D, the cell in figure 3.1 A
and B, does not exhibit T-type current as demonstrated by the lack of a shoulder in the
current-voltage relationship.
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Calcium current demonstrates rapid run-up or run-down of currents. Thus, it was
important to obtain control and baclofen data in the shortest time period possible. To
investigate GABAB mediated effects on HVA currents, the cells were held at -80 mV and
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Figure 3.1: Calcium currents isolated in hippocampal neurons from 7 day old rats. (A) and (C)
represent families of whole cell calcium currents elicited from a holding potential of -80 with 300
msec long depolarizing test steps from -50 mV to +50 mV in 10 mV increments. (B) and (D)
represent the current-voltage relationship of the total calcium current from the same cells shown
in (A) and (C).

depolarized with a 300 msec pulse to +10 mV. This allowed for rapid measurements in
varying conditions (control, drug, and washout) minimizing run-up or run-down.
Calcium currents in cultured hippocampal neurons isolated from postnatal rats of varying
ages are modulated by activation of GABAB receptors with baclofen. Three different
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responses are seen with baclofen application. Calcium currents either demonstrate a
decrease, an increase, or no change in response to GABAB receptor activation (Figure
3.2).
A. Decrease

B. No Change

C. Increase

100 msec

50 pA

50 pA

200 pA

Control
Baclofen
Washout

100 msec

100 msec

Figure 3.2: Total calcium currents were measured using whole-cell voltage clamp. The cells
were held at -80 mV and stepped to +10 mV for 300 msec. The black trace represents the control
current, the red trace represents when 10 µM baclofen was applied to the cell, and the blue trace
represents the currents after baclofen was washed off of the cell. (A) This cell illustrates
inhibition of total calcium current in the presence of 10 µM baclofen. (B) This cell did not show
a response to 10 µM baclofen application. (C) This cell shows facilitation of total calcium
current in response to 10 µM baclofen.

Time Course of Calcium Current Modulation by GABAB Receptors
To determine whether facilitation of L-type calcium current by GABAB receptor
activation is developmentally regulated, calcium currents were recorded in neurons
isolated from hippocampi of 0, 3, 7, and 14 day old rat pups using whole-cell voltage
clamp recording in the absence and presence of the GABAB agonist baclofen (10 µM).
Currents were elicited by a 300 msec depolarizing pulse from a holding potential of -80
mV as described in Chapter 2. A total of 22-32 cells from each developmental time point
studied were analyzed to determine both the percent of total cells that exhibited each
response to baclofen application and the average magnitude of the response. In addition,
both the peak and sustained components of the currents were analyzed. Measuring the
sustained component of the current at the end of a 300 msec pulse should minimize the
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contributions from P/Q-type and N-type calcium currents, thereby increasing the
contribution of L-type calcium current.
The percentage of cells demonstrating an increase, decrease, or no change in total
calcium current depended on the age from which the neurons were isolated. At the early
time points more neurons demonstrated a decrease in peak calcium current in response to
application of 10µM baclofen, while more neurons demonstrated an increase in peak
calcium current at the later time points studied (decrease, P = 0.039; increase P < 0.001;
using a Chi-square, Figure 3.3A). In cultures isolated from 0 day old animals, 59.1% of
the cells demonstrated an inhibition of peak calcium current in response to baclofen
application. The percentage of cells demonstrating a decrease in peak calcium current
was not significantly different in cultures isolated from 3 day old animals (30.5%).
However, the percentage of cells demonstrating a decrease in peak calcium current was
significantly lower in 7 day old animals (25%, P = 0.022, pairwise comparisons were
determined with a Fisher’s Exact test) and 14 day old animals (25%, P = 0.035, pairwise
comparisons were determined with a Fisher’s Exact test). In the cells that demonstrated a
decrease in peak calcium current from hippocampal cultures isolated from 0 day old rats,
the average decrease in total current was 20.30 ± 2.95 % (Figure 3.3B). The average
percent decrease was not significantly different from the other time points studied (P =
0.543 using an ANOVA). In comparison to the cells demonstrating a decrease in peak
current, more cells demonstrated an increase in peak current in response to baclofen
application during the second postnatal week. The percent of cells that demonstrated
facilitation of peak calcium current is different at the various ages studied (P < 0.001
using a Chi-square). Only 9.1% of cells isolated from 0 day old animals and no cells
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isolated from 3 day old rat pups demonstrated an increase in peak calcium current. The
percent of cells demonstrating an increase in peak calcium current was 31.3% in cultures
isolated from 7 day old rat pups and 16.7% in cultures isolated from 14 day old rat pups.
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Figure 3.3: Modulation of peak calcium currents by GABAB receptor activation at different
developmental time points. (A) Each bar represents the percentage of cells demonstrating a
decrease, no change, or an increase in peak calcium current following application of 10 µM
baclofen in hippocampal cultures isolated from postnatal rats ranging from 0 days to 14 days old.
(B) Average percent decrease in peak current in cells demonstrating a decrease in response to
baclofen (P = 0.543 using an ANOVA).
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Peak current is a combination of L-type, N-type, P/Q-type, R-type, and T-type
calcium current hampering interpretation of these data. Thus, the sustained current
component at the end of a 300 msec depolarization pulse to +10 mV was measured
minimizing the contribution of N-type, P/Q-type, and R-type calcium current while
maximizing the contribution of L-type calcium current to the total measurement.
Previous studies in the laboratory have already confirmed that the facilitatory effect of
GABAB receptor activation on calcium currents was entirely mediated through L-type
channels (Carter and Mynlieff, 2004). There was not a significant difference in the
percent of cells demonstrating facilitation of sustained calcium current in response to
baclofen application in hippocampal cultures isolated from 0, 3, 7, or 14 day old rat pups
when time points were analyzed separately (Figure 3.4A; P = 0.054 using a Chi-Square).
Since the number of cells isolated from 0 and 3 day old rats responding with facilitation
were very low and similar and the numbers of cells isolated from 7 and 14 day old rats
responding with facilitation were much higher, the data were re-analyzed and grouped
into early postnatal (day 0-3) and late postnatal (day 7-14) time points. When the cells
were grouped into early and late postnatal period, they were significantly different (P =
0.023 using a Chi-Square). The average percent increase in sustained calcium current in
the cells that demonstrated an increase in calcium current with baclofen treatment were
not significantly different at the developmental time points studied (Figure 3.4B; P =
0.136 using an ANOVA). The cells from 3 day old animals were not included in the
statistical analysis, because there were only 2 cells that demonstrated an increase in
response to baclofen. These experiments demonstrated that the percent of cells
demonstrating facilitation of L-type calcium current by GABAB receptor activation does
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vary throughout the first two weeks of development and is most prominent during the
second postnatal week.
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Figure 3.4: GABAB receptor facilitation of sustained calcium currents at different developmental
time points. Currents were measured at the end of a 300 msec depolarizing pulse to +10 mV from
a holding potential of – 80 mV. (A) Each bar represents the percent of cells demonstrating an
increase in sustained calcium current following application of 10 µM baclofen in hippocampal
cultures isolated from rats that were 0, 3, 7, and 14 days old ( p = 0.054 using a Chi-Square when
each age was analyzed separately; P = 0.023 using a Chi-Square when day 0 and day 3 were
grouped into early postnatal period and day 7 and day 14 were grouped into late postnatal period).
(B) Average percent increase of sustained current in cells demonstrating facilitation in response
to baclofen (P = 0.136 using an ANOVA).
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HVA and LVA Current Densities During the First Two Postnatal Weeks
One possible explanation for the varying baclofen responses seen at the different
developmental ages studied could be due to changes in the number and type of channels
present on the cell membrane. For example, if a particular HVA current type, such as Ltype current is only modulated at earlier time points, it is possible that these channels are
only expressed at that developmental time point. To determine whether there are changes
in current density, both the mean LVA and HVA current densities were measured at the
different ages studied. The LVA or T-type calcium current was elicited from a 300 msec
pulse to -30 mV from a holding potential of -80 mV (Figure 3.5). LVA current density
was determined by dividing the peak control current in these cells by the membrane
capacitance. Since T-type calcium current varies throughout development, not all of the
cells exhibited this type of current at the different time points studied (0 day (9/27), 3 day
(9/29), 7 day (24/43) and 14 day (23/43)). T-type current density did not significantly
differ when cultures were isolated from rats of varying ages (P = 0.107 using an
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Figure 3.5:
T-current density in
hippocampal neurons isolated from rat
pups of different ages. The low
voltage activated T-type calcium
current was elicited by a 300 msec
pulse to -30 mV from a holding
potential of -80 mV. Only a subset of
cells exhibited T-current in cultures
obtained from 0 day (9/27), 3 day
(9/29), 7 day (24/43) and 14 day
(23/43) old rats. The current density
was determined by dividing the peak
control current in these cells by the
membrane capacitance. (P = 0.107
using an ANOVA).

56
In addition to the LVA current density, HVA current densities were also
determined for all of the cells studied at the different time points. HVA currents were
elicited with a 300 msec pulse to +10 mV from a holding potential of -80 mV (Figure
3.6). The peak and sustained components were separated and compared at each time
point studied. The peak current was measured at the beginning of the 300 msec pulse and
the sustained current was measured at the end of the 300 msec pulse. HVA current
density was determined by dividing the current by the cell capacitance. Both the peak
and sustained current densities did not significantly change during the first two postnatal
weeks of development in the rat hippocampus (peak, P = 0.644; sustained, P = 0.508;
using an ANOVA).
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Figure 3.6: HVA current density in hippocampal neurons isolated from rat pups of different
ages. HVA currents were elicited with a 300 msec pulse to +10 mV from a holding potential of 80 mV. The peak current was measured at the beginning of the 300 msec pulse and the sustained
current was measured at the end of the 300 msec pulse. Current density was determined by
dividing the current by the cell capacitance. Both the peak (solid circles) and sustained (open
circles) current densities did not significantly change during the first two postnatal weeks of
development in the rat hippocampus (peak, P = 0.644; sustained, P = 0.508; using an ANOVA).
The N’s ranged from 23-38 for each time point.
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Due to the heterogeneity of our hippocampal cultures, it is possible that a cell type
with a particular cell size or current density may demonstrate facilitation of L-type
current by GABAB receptor activation. To determine whether cells demonstrating an
increase in sustained calcium current in response to baclofen application were different in
cell size or the number and type of calcium channels present when compared to cells
demonstrating no change or a decrease in sustained calcium current in response to
baclofen application, cell size and HVA current densities were compared for the different
groups of cells. There were no significant differences in cell size (P = 0.911 using a Two
Way ANOVA) as measured by cell capacitance or peak current density (P = 0.690 using
a Two Way ANOVA) in the cells that exhibited an increase in sustained calcium current
in response to 10 µM baclofen application when compared to cells that exhibited no
effect or a decrease in sustained calcium current in response to 10 µM baclofen (Figure
3.7). Peak current density was determined by dividing the peak control current by the
cell capacitance to normalize for cell size. There was no significant difference when
determining the current density using the sustained component (P = 0.633 using a Two
Way ANOVA) and the transient component (P = 0.921 using a Two Way ANOVA) of
the current (Figure 3.8). The sustained control current was measured at the end of the 300
msec pulse and the transient component was calculated by subtracting the sustained
current from the peak current for each cell and averaged for each group of cells. These
experiments demonstrated that facilitation of L-type calcium current by GABAB receptor
activation is most prominent in neurons isolated from 7 and 14 day old rats. However,
the changes in response to baclofen can not be attributed to changes in HVA current
density.

58

Average Membrane Capacitance (pF)

A
30

Cells that Demonstrated an Increase
Cells that Demonstrated No Change or a Decrease

25
20
15
10
5
0

0 Day

3 Day

7 Day

14 Day

Average Current Density (pA/pF)

B
20
Cells that Demonstrated an Increase
Cells that Demonstrated No Change or a Decrease

15

10

5

0

0 Day

3 Day

7 Day

14 Day

Figure 3.7: Membrane capacitance and HVA current density. (A) Membrane capacitance was
measured as an indication of cell size. There was not a significant difference in capacitance
between cells that demonstrated an increase in response to 10 µM baclofen (black bars; 0 day
(3/22), 3 day (2/23), 7 day (10/32) and 14 day (6/24)) when compared to cells that demonstrated
no change or a decrease in response to 10 µM baclofen (gray bars) at the different time points
studied (P = 0.911 using a Two Way ANOVA). (B) Total current density was determined by
dividing the peak control current by the cell capacitance to normalize for cell size. The average
current densities were determined at each developmental time point for cells that exhibited an
increase in sustained calcium current with 10 µM baclofen (black bars; 0 day (3/22), 3 day (2/23),
7 day (10/32) and 14 day (6/24)) and cells that exhibited no change or a decrease in sustained
calcium current with 10 µM baclofen (gray bars). There was no difference in the average current
densities based on the cell’s response to baclofen at the different time points studied (P = 0.690
using a Two Way ANOVA).
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Figure 3.8: HVA current density. (A) Average current densities of the sustained component of
current prior to the application of baclofen were determined for cells that exhibited an increase in
sustained calcium current with 10 µM baclofen (black bars; 0 day (3/22), 3 day (2/23), 7 day
(10/32) and 14 day (6/24)) and cells that exhibited no change or a decrease in sustained calcium
current with 10 µM baclofen (gray bars). There were no differences in the average sustained
current densities based on the cell’s response to baclofen at the different time points studied (P =
0.690 using a Two Way ANOVA). (B) There were no significant changes in the transient current
densities between cells that exhibited an increase in sustained calcium current with 10 µM
baclofen (black bars; 0 day (3/22), 3 day (2/23), 7 day (10/32) and 14 day (6/24)) and cells that
exhibited no change or a decrease in sustained calcium current with 10 µM baclofen (gray bars; P
= 0.921 using a Two Way ANOVA).
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DISCUSSION
GABAB receptors have been shown to attenuate N-type calcium current in a
number of different cell types, including hippocampal neurons (Scholz and Miller, 1991;
Dolphin and Scott, 1987; Mintz and Bean, 1993; Pfrieger et al., 1994; Amico et al., 1995;
Cardozo and Bean, 1995; Lambert and Wilson, 1996; Shen and Slaughter, 1999). N-type
calcium channels along with P/Q-type calcium channels are concentrated in synaptic
terminals of CNS neurons and are involved in neurotransmitter release. N-type calcium
channels contribute to neurotransmitter release earlier in development, whereas P/Q type
calcium channels along with N-type calcium channels contribute to neurotransmitter
release later in development (for review see Dolphin, 2003). This correlates to the
present results, which demonstrated that the inhibition of peak calcium current by
GABAB receptors predominates in hippocampal cultures isolated from 0 day old rat pups.
Carter and Mynlieff (2004) have demonstrated that the decrease in peak current by
GABAB receptor activation is through N-type calcium channels. In vivo, GABAB
receptors involved in the inhibition of calcium current are likely to be localized on the
presynaptic terminal providing a type of feedback inhibition of neurotransmitter release.
Much less is known about the facilitatory actions of GABAB receptor activation
on calcium currents. To date, facilitation of L-type calcium current by GABAB receptor
activation has only been observed in salamander retinal neurons (Shen and Slaughter,
1999) in adrenal chromaffin cell cultures (Parramόn et al., 1995), and in hippocampal
neurons (Carter and Mynlieff, 2004). Carter and Mynlieff (2004) were the first to
demonstrate facilitation of L-type calcium current in the mammalian CNS. In their study,
30% of the cells demonstrated an enhancement of calcium current in response to baclofen
application in hippocampal cultures isolated from 5 to 7 day old rat pups. This
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enhancement of calcium current by GABAB receptors was blocked in the presence of the
L-type channel blocker, nimodipine (Carter and Mynlieff, 2004). Since this phenomenon
has only been observed in neonates and has not been previously observed in either
embryonic or adult hippocampal tissue, it seemed likely that the facilitation of L-type
calcium current by GABAB receptors is only present at a specific time in development.
The current study demonstrated that facilitation of L-type calcium current by
GABAB receptor activation is a developmental phenomenon and is greatest in
hippocampal cultured isolated from 7 and 14 day old rats. When analyzing the peak
component of the current 31% of the cells demonstrated an increase in total calcium
current and when analyzing the sustained current component 37.5% of the cells
demonstrated an increase in calcium current in response to baclofen application in
hippocampal cultures isolated from 7 day old rat pups. These percentages are consistent
with the 30% of cells that Carter and Mynlieff (2004) found to be facilitated by GABAB
receptor activation in hippocampal cultures isolated from 5 to 7 day old rats.
Hippocampal cultures are heterogeneous and contain pyramidal cells along with several
types of inhibitory interneurons. There are over 21 distinguishable inhibitory interneuron
subtypes that have been classified in the hippocampus based on their morphological,
neurochemical, and electrophysiological characteristics (for review see Klausberger and
Somogyi, 2008; Cutsuridis and Wennekers, 2009; Klausberger, 2009). The variability in
the responses to baclofen application is likely due to the heterogeneity of the cultures.
Several factors such as the complement of calcium channels, the presence of GABAB1a
versus GABAB1b receptors subtypes, the coupling with different G-proteins, the size, and
the physical location of the cells can all vary in the different cell types present within the
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hippocampus. Therefore, the cells demonstrating facilitation in response to baclofen
application could represent a specific subset of cells present in the hippocampus.
Despite the heterogeneity of the cell cultures, experiments on HVA and LVA
current density at various time points in this early postnatal period suggest that a global
change in channel density or distribution of channel types in the cells cannot explain the
differing effects of GABAB receptor activation at different time points. The sizes of the
cells that demonstrated facilitation were not different when compared to cells that
demonstrated no change or a decrease in calcium current in response to baclofen
application. In addition, the HVA current density for cells that demonstrated facilitation
was not different when compared to cells that demonstrated no change or a decrease in
calcium current in response to baclofen application when the HVA current density was
determined for the total, sustained, and transient component of the current. These studies
suggest that cells demonstrating facilitation of calcium current by GABAB receptors do
not differ significantly in the size or number of channels present from cells demonstrating
no change or a decrease in calcium current by GABAB receptors.
Even though there are not changes in the total amount of sustained current
throughout development, there may be variations in the contribution of the different
forms of L-type calcium channels. The two types of L-type calcium channels that are
ubiquitously expressed in the brain and are present in hippocampal neurons are Cav1.2
and Cav1.3 (Hell, 1993). It has been demonstrated that L-type Cav1.2 protein levels peak
in hippocampal neurons isolated from 7 day old rats (Nuñez and McCarthy, 2007),
whereas Cav1.3 protein levels begin low and increase throughout development (Ingraham
and Mynlieff, unpublished data). Electrophysiological experiments in native neurons do
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not distinguish between Cav1.2 and Cav1.3 current. A peak facilitation of L-type calcium
current by baclofen at approximately one week may be a reflection of the peak expression
of Cav1.2 protein levels in these neurons. This idea is also supported by the fact that
immunocytochemical techniques have shown that less than 30% of hippocampal neurons
taken from 7 day old pups demonstrate significant amounts of the Cav1.2 channels, which
may reflect the subset of cells that demonstrate the facilitation of L-type calcium current
by GABAB receptors.
Our lab has demonstrated that GABAB receptor activation within the neonatal rat
hippocampus can modulate different types of VDCCs. Here we have demonstrated that
the inhibitory effect predominates during the first postnatal week, while the facilitatory
effect of calcium current by GABAB receptor activation predominates during the second
postnatal week. Carter and Mynlieff (2004) have demonstrated that both effects can be
present within the same cell, which suggests different mechanisms are involved with the
modulation of the different channel types by GABAB receptors. L-type calcium channels
contain several consensus phosphorylation sites for several kinases, including PKC and
PKA, while N-type calcium channels are primarily modulated through direct interaction
by G-proteins associated with the GABAB receptor(for review see Catterall, 2000). The
signal transduction mechanism involved in the facilitation of L-type current by GABAB
receptors is an area of interest in the laboratory and will be discussed in Chapter 5.
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CHAPTER 4

The influx of calcium through L-type calcium channels is
necessary for the upregulation of KCC2, but not NKCC1
during development in the rat hippocampus
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INTRODUCTION
Early in neuronal development the neurotransmitter GABA exerts an excitatory
rather than inhibitory effect due to a high concentration of intracellular chloride ions
(Cherubini et al., 1991). During the first two postnatal weeks in the hippocampus of rats
the internal concentration of chloride ions decreases. This causes a change in the reversal
potential of chloride and thus, a shift from an excitatory effect of GABAA receptor
activation to an inhibitory effect (Ben-Ari et al., 1989; Leinekugel et al., 1995, 1997,
1998; Khazipov et al., 1997; Rivera et al., 1999; Ganguly et al., 2001). Evidence
suggests that the upregulation of the K+Cl- co-transporter (KCC2) and the
downregulation of the Na+K+2Cl- co-transporter (NKCC1) are responsible for shifting the
chloride reversal potential (Plotkin et al., 1997; Lu et al., 1999; Rivera et al., 1999;
Hübner et al., 2001a). NKCC1 expression predominates in immature neurons and
mediates chloride influx, while KCC2 expression predominates in mature neurons and
mediates chloride efflux (for review see Delpire, 2000; Payne et al., 2003). Due to the
high intracellular chloride concentration in immature neurons the activation of GABAA
receptors depolarizes the cell, which subsequently activates voltage-dependent calcium
channels, particularly L-type calcium channels (Yuste and Katz, 1991; Leinekugel et al.,
1995; Khazipov et al., 1997; Ganguly et al., 2001). This GABAergic excitation is
important for proper neuronal development (for review see Ben-Ari, 2002; Owens and
Kriegstein, 2002; Fiumelli and Woodin, 2007; Galanopoulou, 2008; Kahle et al., 2008;
Blaesse et al., 2009). As the brain matures, the number of neurons that are excitatory in
response to GABA decreases and thus, the magnitude of calcium influx with GABA
receptor activation decreases. Once neurons have fully developed, GABA responses are
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hyperpolarizing and inhibit the cell from reaching threshold. Additionally, the subunit
composition of the GABAA receptor changes during development (Kanaumi et al., 2006;
Liu and Wong-Riley, 2006; Rissman et al., 2006; Yu et al., 2006). This change in
subunit composition should not affect the reversal potential directly since that is
dependent on the internal and external chloride concentrations, but it does affect the
response to various modulators such as zinc and benzodiazepines.
Treatment of embryonic rat hippocampal cultures with L-type calcium channel
antagonists prohibits the shift in the chloride reversal potential, suggesting that calcium
influx through L-type calcium channels is involved in the changes of chloride transporter
expression (Ganguly et al., 2001). However, Ganguly and co-workers did not directly
look at the effect of calcium influx through L-type channels on chloride transporter
expression. Previous experiments in our laboratory have demonstrated facilitation of Ltype calcium current by activation of the metabotropic GABAB receptor in acutely
cultured hippocampal neurons isolated from 5-7 day old rat pups (Carter and Mynlieff,
2004). The data presented in Chapter 3 suggest that the facilitation of L-type calcium
current is maximal in the second postnatal week, a time period in which many genes
including chloride transporters and neuronal L-type calcium channels are changing their
expression as the neurons mature (Nuñez and McCarthy, 2007).
The present study explores the potential connection between chloride transporter
expression and calcium influx through L-type calcium channels in the early neonatal
period. Although changes in reversal potential have been shown to be dependent on
calcium influx through L-type calcium channels, this is the first study to directly
investigate the effect of calcium influx on the chloride transporter protein levels in
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hippocampal neurons. Since calcium influx is enhanced in a subset of neonatal
hippocampal neurons by activation of GABAB receptors, activation of these receptors
may also alter KCC2 and NKCC1 transporter expression. The KCC2 and NKCC1
expression levels throughout early postnatal development were determined by Western
blot analysis in the presence and absence of an L-type channel antagonist and a GABAB
receptor agonist.
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RESULTS
Developmental Regulation of NKCC1 Protein during the Early Postnatal Period
The expression levels of both KCC2 and NKCC1 were determined by Western
blot analysis in hippocampal neurons cultured for various time periods and were
compared to that from fresh tissue of equivalent ages. KCC2 is neuron specific, whereas
NKCC1 is expressed in neurons and also glial cells (Payne et al., 1996; Lu et al. 1999;
Kanaka et al., 2001; Hübner et al., 2001b). Whole hippocampal tissue protein was
isolated from rats ranging in ages 1 day to 42 days old and cultured hippocampal neurons
that were isolated from 0 day old rat pups and kept in culture for 1 to 15 days. Other
investigators have demonstrated that embryonic hippocampal neurons in culture exhibit
spontaneous activity and form synaptic connections within a few days following
dissociation (Siebler et al., 1993; Bi and Poo, 1998; Vicario-Abejón et al., 1998). In
addition, postnatal cultured hippocampal neurons in the Mynlieff laboratory demonstrate
excitatory postsynaptic currents if allowed to remain in culture for more than 24 hours
(unpublished observations). Anti-NKCC1 antibodies labeled a single band of 143 kDa
on Western blots of proteins isolated from either cultured neurons or whole hippocampus
(Figure 4.1). Steady state NKCC1 protein levels were determined at each time point
studied by dividing the IOD for the 143 kDa band by the IOD for a band labeled with βtubulin antibodies to control for variations in loading. The internal control was necessary
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Figure 4.1: Using Western blot
analysis, anti-NKCC1 antibodies label
a single band with a molecular weight
of 143 kDa in protein preparations
extracted from whole hippocampus or
cultured hippocampal neurons (right
lane). The left lane was loaded with
MagicMark Western standard markers.
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since the amount of protein extracted from cultured neurons was so low that the protein
assay results were not accurate. In contrast to KCC2 protein levels (see below), there
was little change in the steady state protein levels of NKCC1 during the first two
postnatal weeks of development both in fresh tissue and in cultured hippocampal neurons
(Figure 4.2; P = 0.278 using Two Way ANOVA). Fresh tissue that was analyzed from
rats of one month or more in age demonstrated up to a ten-fold increase in the steady
state expression level of NKCC1 compared to D1 protein levels (D42, 13.17 ± 4.32).
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Figure 4.2: Developmentally regulated expression of NKCC1 protein in rat hippocampus and
cultured hippocampal neurons. (A) Representative Western blot analysis of proteins extracted
from whole hippocampus (left panel; postnatal day 1 to day 15) and cultured hippocampal
neurons (right panel). Cultured neurons were obtained from day 0 rats and were kept in culture
for 1 to 15 days before protein isolation (C0-1 to C0-15). (B) Summary data comparing the
steady state NKCC1 protein levels isolated from whole hippocampal protein extracts (solid
circles; N = 3) and cultured hippocampal neurons (open circles; N = 3 – 4, except C0-6 where N
= 2). The IOD of the band labeled with NKCC1 antibodies (143 kDa) was divided by the IOD of
the band labeled with β-tubulin antibodies (55 kDa) for normalization. In the first two weeks
there was no difference in NKCC1 protein levels in the different ages across both tissue types
(P = 0.278 using a Two Way ANOVA).
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Developmental Regulation of KCC2 Protein during the Early Postnatal Period
Functional KCC2 proteins form oligomers that have a molecular mass higher than
the monomeric protein (~125 kDa). Several studies have demonstrated KCC2 dimers
along with monomers when performing Western blot analysis (Lu et al., 1999; Blaesse et
al., 2006; Zhang et al., 2006). KCC2 dimers are detected on Western blots, because they
are resistant to both non-ionic detergents such as Triton X-100 and also the anionic
detergent SDS (Blaesse et al., 2006). In our study, antibodies to KCC2 labeled three
bands of 248 kDa, 125 kDa, and 46 kDa representing a dimer, a monomer, and a splice
variant (Figure 4.3). As the neurons matured there were increasing amounts of the dimer
in relation to the monomer in both whole hippocampal protein extracts as well as cultured
protein extracts. Steady state KCC2 protein levels were determined at each time point
studied by adding the IOD for the band corresponding to the monomer plus the IOD for
the band corresponding to the dimer and this value was further divided by the IOD for a
band labeled with β-actin antibodies as a control for variations in loading. Since the
intensity of the band corresponding to the KCC2 splice variant was a minor component in
most preparations and the fact that the splice variant is not considered as an active form
of the KCC2 protein, it was not included in the data analysis. Previous studies showed
that KCC2 mRNA levels within the rat hippocampus are low following birth and rapidly
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Figure 4.3: This sample Western blot
demonstrates the three bands labeled
with anti-KCC2 antibodies with
molecular weights of 248 kDa, 125
kDa, and 46kDa in protein preparations
extracted from whole hippocampus or
cultured hippocampal neurons (right
lane). The left lane was loaded with
MagicMark Western standard markers.
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rise in the first few postnatal weeks (Rivera et al., 1999; Balakrishnan et al., 2003). Our
protein data is consistent with the mRNA data in that both fresh tissue and cultured
neurons demonstrated low KCC2 protein levels during the first postnatal week, but levels
rapidly rise during the second postnatal week ((Figure 4.4; P < 0.001 using a Two Way
ANOVA). In fresh tissue the protein level tripled between day 15 and day 24 (D24, 11.86

± 4.2), at which point it plateaued through adulthood (D33, 9.31 ± 0.66; D42 9.60 ±
2.76). The increase in KCC2 protein levels during the second postnatal week in
development occurred both in vivo and in cultured hippocampal cells, supporting the use
of cultured hippocampal neurons to study the developmental expression of KCC2. In
addition, the results presented in Chapter 3 demonstrate that in hippocampal cell cultures
obtained from rats of various ages L-type current facilitation peaks at approximately the
same developmental time point as KCC2 expression levels begin to rise. This supports
the hypothesis that facilitation of L-type calcium current by GABAB receptor activation
within the hippocampus may play a role in the regulation of KCC2 during the first two
postnatal weeks of development.
Other investigators have demonstrated that the internal chloride concentration
decreases during the early postnatal period in rat hippocampal neurons. This could be
due to a concurrent increase in KCC2 with a decrease in NKCC1, since these transporters
move chloride in the opposite direction. However, our data suggest that only the KCC2
transporter levels are changing in the first two postnatal weeks of hippocampal
development and that it is the ratio of the two transporters that is important in
determining the intracellular concentration of chloride and thus, the reversal potential for
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the GABAA response. Our data demonstrate a large increase in the KCC2 to NKCC1
ratio between postnatal day 8 and 12 (Figure 4.5; P = 0.005 using an ANOVA).
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Figure 4.4: Developmentally regulated expression of KCC2 protein in rat hippocampus and
cultured hippocampal neurons. (A) Representative Western blot analysis of proteins extracted
from whole hippocampus (left panel; postnatal day 1 to day 15) and cultured hippocampal
neurons (right panel). Cultured neurons were obtained from day 0 rats and were kept in culture
for 1 to 15 days before protein isolation (C0-1 to C0-15). (B) Summary data comparing the
steady state KCC2 protein levels isolated from whole hippocampal protein extracts (solid circles;
N = 3) and cultured hippocampal neurons (open circles; N = 3 – 4, except C0-6 where N = 2).
The IOD of the band corresponding to the monomer (125 kDa) and the IOD of the band
corresponding to the dimer (248 kDa) were added together and divided by the IOD for the band
labeled with β-actin antibodies (45 kDa). There is a significant difference in KCC2 protein levels
at the different ages across both tissue types (P < 0.001 using a Two Way ANOVA).
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Figure 4.5: KCC2 to NKCC1
ratio. The ratio of KCC2 to
NKCC1 was determined using the
normalized values for the cultured
hippocampal neurons for each date
that a preparation was isolated.
An average of three to four
preparations was determined for
each time point. The ratio of
KCC2 to NKCC1 is higher at 12
and 15 days in culture (P = 0.005
using an ANOVA).
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Role of L-type Calcium Channels and GABAB Receptors in Modulating Chloride
Transporter Expression
To determine whether calcium influx through L-type calcium channels and
GABAB receptor activation affect the protein level of KCC2 and NKCC1 during the early
neonatal period, hippocampal cultures isolated from 0 day rats were treated daily with the
GABAB receptor agonist baclofen (10 µM) or the L-type calcium channel antagonist
nimodipine (5 µM) for one week. Previous studies treating cultures with the vehicles for
these drugs demonstrated only a small shift in pH (<0.1) and no effect on cell viability or
protein levels (data not shown). Steady state NKCC1 protein levels were determined by
Western blot analysis and the values were determined by dividing the IOD for the band
corresponding to NKCC1 by the IOD for a band corresponding to β-tubulin. This value
was further normalized by dividing it by the value obtained for the control culture grown
in the absence of any drugs along side each set of cultures treated with drugs and exposed
to the same film and multiplied by 100%. NKCC1 protein levels during the first
postnatal week were not modified by treatment with the GABAB agonist baclofen
(101.50 ± 8.90%; N = 4 individual cultures, P = 0.8772 using a one sample t-test; Figure
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4.6A). In addition, the L-type calcium channel antagonist nimodipine did not affect the
steady state protein levels of NKCC1 during the first postnatal week of development
(93.50 ± 6.90%; N = 4 individual cultures, P = 0.4177 using a one sample t-test; Figure
4.6A). Therefore, NKCC1 protein levels in hippocampal cultures are not affected by one
week treatment of the GABAB agonist, baclofen or the L-type antagonist, nimodipine.
Steady state KCC2 levels were analyzed by Western blot and the values were
determined by adding the IOD for the band corresponding to the monomer plus the IOD
of the band corresponding to the dimer and dividing it by the IOD for a band labeled by
β-actin antibodies. This value was further normalized by dividing it by the normalized
IOD obtained from the control culture that was run on the same gel and exposed to the
same film and multiplied by 100%. A total of 8 cultures were treated with each drug.
The steady state protein levels of KCC2 after a week in culture were not significantly
altered by treatment with the GABAB agonist baclofen (108.38 ± 12.03%; N = 8, P =
0.5357 using a one sample t-test; Figure 4.6B). The steady state protein levels of KCC2
were greatly reduced by treatment with the L-type calcium channel antagonist
nimodipine (46.38 ± 5.37%; N = 8, P = 0.0001 using a one sample t-test; Figure 4.6B).
Thus, the upregulation of steady state KCC2 expression that normally occurs during the
first postnatal week in culture appears to be dependent, at least in part, on calcium influx
through L-type channels.
In addition to baclofen and nimodipine, a small number of cultures were also
treated with 10 µM 2-OH-saclofen, a GABAB antagonist. 2-OH-saclofen (10 µM) did
not affect the protein levels of KCC2 during the first postnatal week in culture (data not
shown). These results were similar to the data collected from cultures treated with the
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GABAB agonist baclofen, which also did not affect KCC2 protein levels during the first
postnatal week in culture. Therefore, additional experiments were not performed using
the GABAB antagonist 2-OH-saclofen.
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Figure 4.6: Effects of baclofen and nimodipine on chloride transporter expression using Western
blot analysis. Hippocampal cultures were obtained from day 0 rats and either 10 µM baclofen, a
GABAB agonist, or 5 µM nimodipine, an L-type calcium channel antagonist were added daily to
the cultures for one week. Each bar represents one protein preparation that was isolated from a
set of cultures treated with either drug and an average (hatched bar) was determined for both drug
treatments. (A) NKCC1 steady state protein levels following treatment with a GABAB agonist or
an L-type calcium channel antagonist. The IOD of the band labeled with NKCC1 antibodies was
divided by the IOD of the band labeled with β-tubulin antibodies. This value was further
normalized by dividing it by the value obtained for the control culture for each set of cultures and
multiplied by 100%. (B) KCC2 steady state protein levels following treatment with a GABAB
agonist or an L-type calcium channel antagonist. The IOD of the band corresponding to the
monomer and the IOD of the band corresponding to the dimer of KCC2 were added together and
divided by the IOD of the band labeled with β-actin antibodies. This value was further
normalized by dividing it by the value obtained for the control culture for each set of cultures and
multiplied by 100%. (*P = 0.0001 using a one sample t-test).

77
DISCUSSION
GABA is the main inhibitory neurotransmitter within the adult brain. However,
activation of GABAA receptors has an excitatory effect in immature neurons due to the
high intracellular chloride levels (Cherubini et al., 1991). Later in development the
activation of GABAA receptors has an inhibitory effect that persists into adulthood.
Changes in chloride transporter expression levels during the first few postnatal weeks of
development are thought to underlie this developmental switch (Plotkin et al., 1997; Lu et
al., 1999; Rivera et al., 1999; Hübner et al., 2001a). The mechanisms involved in
signaling the shift in transporter expression are not known. It has been demonstrated that
blockade of GABAA receptors or L-type calcium channels delays the change in the
reversal potential of chloride in developing hippocampal neurons (Ganguly et al., 2001).
Prior to the switch in reversal potential for the GABAA receptor, activation of these
receptors causes calcium influx through VDCCs due to the depolarizing nature of the
response. These data from Ganguly and co-workers (2001) suggest that L-type calcium
current may play a role in the changes in chloride transporter expression that occurs in
the rat hippocampus during the first two postnatal weeks of development. Our laboratory
has demonstrated that activation of the GABAB metabotropic receptor can enhance
calcium influx through L-type calcium channels and attenuate calcium influx through Ntype calcium channels during the early neonatal period (Carter and Mynlieff, 2004). The
attenuation of N-type calcium current by GABAB receptors is known to persist into
adulthood in the hippocampus and is likely to modulate neurotransmitter release from the
presynaptic terminal (Dutar and Nicoll, 1988; Harrison, 1990; Lambert et al., 1991;
Thompson and Gähwiler, 1992; Davies and Collingridge, 1993; Pfrieger et al., 1994; Wu
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and Saggau, 1995). The functional role of L-type calcium channel enhancement is less
clear. The present study demonstrated that influx of calcium through L-type calcium
channels is necessary for the upregulation of KCC2 protein levels in the first postnatal
week within the hippocampus. Thus, these findings support the hypothesis that calcium
influx through L-type channels is involved in the developmental switch of the GABAA
response by affecting chloride transporter expression.
Several investigators have described conflicting expression patterns of NKCC1
throughout hippocampal development. Therefore, it was necessary to perform a
timecourse of NKCC1 protein level changes in cultured hippocampal neurons. Our
developmental timecourse of NKCC1 protein levels is consistent with previous studies
looking at NKCC1 mRNA and protein within rat hippocampal neurons (Yan et al., 2001;
Wang et al., 2002). These studies observed an upregulation of both NKCC1 mRNA and
protein in the developing rat hippocampus with a peak level of expression within the
adult. The Western blot analysis of NKCC1 by Yan et al. (2001) demonstrated a trend
for an increase in the first three postnatal weeks but only in the adult was the increase
statistically significant, which is very similar to the data presented here. The preparations
from fresh hippocampal protein also contain glial cells, which are one of the main cell
types that express NKCC1 protein in adult hippocampus (Kanaka et al., 2001; Yan et al.,
2001; Wang et al., 2002). The fact that whole hippocampal preparations contain glial
cells could explain why NKCC1 protein expression levels are higher in the preparations
isolated from adult tissue versus tissue isolated from neonates. However, some studies
have seen peak expression of NKCC1 mRNA and protein within the rat hippocampus at
postnatal day 7 with very little expression in the adult (Plotkin et al., 1997). Our cultures

79
are strictly neuronal and do not support glial cells (Mynlieff, 1997). Fresh tissue
consistently demonstrated higher NKCC1 levels than age matched cultures, which is
likely due to the lack of glial cells in the cultures. Therefore, all NKCC1 protein levels
measured in culture reflect expression within the first two postnatal weeks exclusively in
neurons.
In whole hippocampal protein extracts from 1, 4, and 6 day old rats and in
cultures isolated on day 0 and kept in culture for 1, 4, and 6 days, KCC2 protein levels
remain relatively low. However, in fresh hippocampal extracts as well as in cells kept in
culture, the slope of the KCC2 protein levels drastically increases between day 6 and day
8, correlating well with the peak in the enhancement of L-type calcium current by
GABAB receptor activation during the second postnatal week (Figure 4.7). KCC2 protein
levels continue to rise throughout the first few weeks of development and plateau by
three weeks of age. This trend in KCC2 expression in vivo was similar to what was seen
in our cultured hippocampal neurons as well as by others studying expression of KCC2
by Western blot analysis or mRNA levels (Rivera et al., 1999; Lu et al., 1999; Wang et
al., 2002; Stein et al., 2004; Nuñez and McCarthy, 2007). The fact that there are not
dramatic changes in NKCC1 transporter protein levels during the first two postnatal
weeks suggest that the ratio of KCC2 to NKCC1, versus the downregulation of NKCC1
protein levels may be responsible for the change in the reversal potential of chloride and
thus, the developmental switch of the GABAA response from excitatory to inhibitory.
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Figure 4.7 Comparison of cell percentage demonstrating L-type current
facilitation and KCC2 steady state levels in whole hippocampal protein extracts.
The bar graph represents the percent of cells that exhibited L-type calcium
current facilitation in response to GABAB receptor activation at different
developmental ages. The line graph represents the steady state KCC2 levels in
whole hippocampal protein extracts determined by Western blot analysis.

NKCC1 expression in hippocampal cultures was not affected by either baclofen
or nimodipine treatment. While these data suggest that neither GABAB receptor
activation nor L-type calcium current is directly involved in developmental changes of
NKCC1 protein levels, the involvement of L-type calcium current in KCC2 expression
would still cause a change in the KCC2/NKCC1 ratio. Ultimately, it is the ratio of these
two transporters that determines the internal chloride concentration since they carry
chloride in opposite directions. Thus, a change in just one transporter will alter the ratio
and affect the chloride reversal potential. Relatively little change in the NKCC1 protein
levels during the first two weeks in culture is offset by the large increase in KCC2 protein
levels.
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Treatment of hippocampal cultures with the L-type calcium channel blocker
nimodipine significantly blocked the upregulation of KCC2 protein levels compared to
the cultures not treated with the blocker. Calcium influx through L-type calcium
channels appears necessary to signal a pathway involved in the upregulation of KCC2.
These findings support the model that the elevation of intracellular calcium levels
through VDCCs promotes the developmental switch of the GABAA response from
excitatory to inhibitory. This role of L-type calcium channels in regulating KCC2 protein
levels also suggests that L-type calcium current facilitation by GABAB receptor
activation could enhance the upregulation of KCC2 during the early neonatal period
within the rat hippocampus. However, when cultures were treated with the GABAB
agonist baclofen there was no significant change in KCC2 protein levels compared to the
untreated cultures. There are a number of reasons that enhancement of L-type calcium
current by activation of GABAB receptors may be important in this developmental switch
without demonstrating an effect in the current study. Typically, only about 30% of the
neurons demonstrate an enhancement of the L-type calcium current with GABAB
receptor activation. The effect of baclofen may have been quite significant on the KCC2
expression in these individual cells, but when the tissue was pooled for a Western blot
analysis it would not be sufficient to see a significant change in the protein levels.
Ideally, one would need to perform experiments such as single cell RT-PCR to determine
if the chloride transporters are affected by GABAB receptor activation differently in
distinct cells. In addition, there is still a large amount of L-type calcium current in the
absence of GABAB receptor activation. The activation of the GABAB receptors merely
“enhances” the whole cell current that is already present. To see a difference in protein
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levels by Western blot analysis one needs a very robust change such as that seen with
nimodipine. Perhaps the “enhancement” seen with baclofen was not sufficiently large to
analyzed by this method.
In conclusion, the activation of VDCCs following depolarizing GABAA responses
aids in signaling the developmental switch of the GABAA response from excitatory to
inhibitory. Here we have demonstrated that L-type calcium current plays a role in the
upregulation of KCC2 protein levels during the first few weeks of hippocampal
development without causing a significant change in the NKCC1 protein levels.
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CHAPTER 5

The signal transduction mechanism of L-type calcium current
facilitation by GABAB receptor activation in the
neonatal rat hippocampus

84
INTRODUCTION
The regulation of N-type as well as P/Q-type calcium channels has been well
studied in neurons. Less is known about the regulation of L-type calcium channels in
neurons. L-type calcium channels play a large role in the function of both cardiac and
skeletal muscle. Thus, many investigators have concentrated on studying the regulation
of L-type calcium channels in muscle tissue, particularly cardiac muscle. Neuronal
activity is commonly regulated by GABA, which can activate metabotropic GABAB
receptors. Upon GABAB receptor activation, neuronal calcium channels can be directly
regulated by either Gα or Gβγ subunits or they can be indirectly regulated by G proteins
through second messenger systems (for review see Catterall, 2000; Dolphin, 2003;
Tedford and Zamponi, 2006).
It has been demonstrated that GABAB receptors predominantly couple to Gi/o
proteins (Morishita et al., 1990; Campbell et al., 1993; Menon-Johansson et al., 1993;
Greif et al., 2000). One of the most common mechanisms of channel modulation by
GABAB receptor activation occurs through direct modulation by Gβγ subunits associated
with Gαi/o proteins (for review see Bettler et al., 2004). In the hippocampus, inhibition of
N-type and P/Q-type calcium channels by presynaptic GABAB receptor activation occurs
through direct modulation by Gβγ subunits (Kajikawa et al., 2001). Binding of Gβγ
subunits to the channel inhibits its activity by making it more difficult for the channel to
open (Bean, 1989b; Boland and Bean, 1993; Herlitze et al., 1996; Ikeda, 1996; Zamponi
and Snutch, 1998; Colecraft et al., 2000). GIRK channels are directly activated by Gβγ
subunits associated with Gαi/o proteins coupled to GABAB receptors. GIRK channels can
also be modulated through kinase activity. PKA increases the activation of GIRK
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channels, whereas PKC decreases the activation of GIRK channels (for review see Luján
et al., 2009).
Previous experiments have demonstrated that GABAB receptor activation can lead
to an attenuation of N-type calcium current and the enhancement of L-type calcium
current in hippocampal cultures obtained from neonatal rat pups of various ages (Carter
and Mynlieff, 2004; Bray and Mynlieff, 2009). It is well known that the inhibition of Ntype calcium current by GABAB receptor activation is mediated by a G-protein from the
Gi/o protein family, which are sensitive to PTX. However, the signal transduction
pathway involved in the facilitation of L-type current by GABAB receptors in mammalian
neurons is unknown.
In addition to direct modulation by Gβγ, activation of G-proteins can also lead to
activation of kinases, which can modulate calcium channel activity as well. L-type
calcium channels have several consensus sites for phosphorylation by PKC and PKA.
PKC is typically activated through the Gαq/11 pathway and PLC. PKA activation is
dependent on the presence of cAMP. The levels of cAMP are determined by adenylyl
cyclase activity, which can either be stimulated by Gαs or inhibited by Gαi. GABAB
receptor activation of PKC and PKA has been shown to facilitate L-type calcium current
in a subset of salamander retinal neurons (Shen and Slaughter, 1999). It has been
demonstrated specifically within the rat hippocampus, that activation of PKC can
facilitate L-type calcium current (Doerner and Alger, 1992). However, this response was
not directly linked to GABAB receptors.
This study was designed to elucidate the signal transduction mechanism of
GABAB receptor modulation of L-type calcium channels within the neonatal rat
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hippocampus. Although activation of PKC has been shown to enhance L-type calcium
current within the hippocampus, this is the first study to directly investigate the potential
role of PKC in GABAB receptor mediated facilitation of L-type calcium current.
Electrophysiological experiments were performed on cultured hippocampal neurons in
the presence and absence of several PKC and PKA antagonists, as well as agonists for
both types of kinases to determine their involvement in the signaling pathway of GABAB
receptor activation and the subsequent enhancement of L-type calcium current. Calcium
current facilitation in response to baclofen application has been shown to be most
prominent in hippocampal cultures isolated from 7 and 14 day rat pups. Therefore, all
hippocampal cultures used in these experiments were isolated from rat pups that were 6
to 8 days old in order to maximize the number of cells exhibiting the facilitatory
response.
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RESULTS
Since one of the most common mechanisms of channel modulation by GABAB
receptor activation occurs through direct modulation by a Gi/o protein, the first
experiment performed was overnight treatment of hippocampal cultures obtained from 7
day old rat pups with PTX (200 ng/ml). PTX was added to the cultures two hours after
dissociation. Addition of PTX inactivates Gi/o proteins by ADP-ribosylation. As
described in Chapter 2, calcium currents were elicited by a 300 msec depolarizing pulse
to +10 mV from a holding potential of -80 mV (Figure 5.1). The distribution of the
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Figure 5.1 Calcium currents in the presence of PTX. Calcium currents were elicited by a 300
msec depolarization to +10 mV from a holding potential of -80 mV. The peak current is
measured at the beginning of the 300 msec pulse. The black trace represents the control current,
the red trace represents when 10 µM baclofen was applied to the cell, and the blue trace
represents the currents after baclofen was washed off of the cell. The cell represented in A and B
did not show an effect to baclofen application in the presence of PTX, whereas the cell
represented in C and D demonstrated facilitation of peak calcium current in response to baclofen
application in the presence of PTX.
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responses differed in cultures that were treated with PTX in comparison to non-treated
cultures (P = 0.009 using a Chi-square). In cultures that were not treated with PTX,
33.33% of cells demonstrated a decrease, 38.46% of cells demonstrated no change, and
28.21% of cells demonstrated an increase in peak calcium current in response to 10 µM
baclofen. In cultures that were treated with PTX, no cells demonstrated a decrease, 70%
of cells demonstrated no change, and 30% of cells demonstrated an increase in peak
calcium current in response to 10 µM baclofen. Facilitation of calcium current in
response to 10 µM baclofen was still seen in cells treated with PTX, which suggests that
facilitation of L-type calcium current is not mediated by a PTX sensitive G-protein
(Figure 5.2). However, it was demonstrated that the inhibition of N-type calcium current
by GABAB receptors in the neonatal rat hippocampus is mediated through a Gi/o protein,
because following PTX treatment no cells demonstrated inhibition of their current (P =

% Cells Exhibiting Response

0.002 using a Fisher’s Exact test for pairwise comparisons).
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Figure 5.2: Effect of PTX on the baclofen responses in hippocampal neurons. The peak
component of calcium current was measured at the beginning of a 300 msec depolarizing pulse to
+10 mV from a holding potential of -80 mV. Cells were classified as demonstrating a decrease
(black bar), no change (light gray bar), or an increase (dark gray bar) in response to 10 µM
baclofen. Data were collected from 39 control cells and 20 cells in the presence of PTX (200
ng/ml, P = 0.009 using a Chi-square). Pairwise comparisons were done with a Fisher’s Exact
Test. * indicates a statistically significant difference.
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PKC Inhibitors Block the Ability of Baclofen to Facilitate Sustained Current
The goal of these experiments was to determine whether or not PKC was involved
in the signal transduction pathway of L-type calcium current facilitation by GABAB
receptors. Although over 12 different isoforms of PKC have been classified, broadspectrum PKC inhibitors were used as a first step in determining the involvement of PKC
in the signal transduction pathway of the facilitatory response by GABAB receptor
activation. Several PKC inhibitors with different chemical structures were used for
verification of the results. Each of the inhibitors used has been shown to be a potent and
selective inhibitor of PKC (Table 5).
PKC Inhibitors
PKC Fragment 19-36

PKC Isoforms
All isoforms

GF-109203X

α, β1, βII, δ, ε, ζ, γ

Chelerythrine Chloride

Group A and Group B
(α, βI, βII, γ) (δ, ε, ζ, η)

References
House and Kemp, 1987
Toullec et al., 1991;
Martiny-Baron et al., 1993
Herbert et al., 1990

Table 5. The PKC inhibitors used were selective for several PKC isoforms.

The first PKC inhibitor tested was the PKC fragment 19-36, which corresponds to
a conserved region of the regulatory domain of PKC. This synthetic peptide fragment
has been shown to inhibit both autophosphorylation and substrate phosphorylation of
PKC by acting as a potent substrate antagonist (House and Kemp, 1987). This peptide
was shown to block the facilitation of L-type calcium current by GABAB receptors in
salamander retinal cells (Shen and Slaughter, 1999). Since the PKC fragment 19-36 is
not membrane permeable, it was included in the internal pipette solution. For all PKC
and PKA antagonists and agonists, the sustained component of the current was analyzed
to maximize the contribution of L-type calcium current. It is well documented that
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voltage-dependent calcium currents run down or run up in recordings made from cultured
cells, which makes the ability to hold a cell through numerous drug applications and
washes limited. Therefore, all experiments with kinase inhibitors and activators were
carried out as population studies, comparing the distribution of responses in the presence
and absence of each compound tested. In addition to the comparison of the percent of
cells demonstrating each response to baclofen application, the average percent change in
the magnitude of sustained current was also compared back to the average percent change
seen in hippocampal cultures isolated from 6 to 8 day old rats that were treated with
baclofen in the absence of any kinase inhibitors or activators (Figure 5.3).

Average % Change in
Sustained Calcium Current

30
(N = 16)
20
10
0
(N = 13)
-10
-20

(N = 15)

-30

Figure 5.3: Summary of the average percent change in sustained calcium current in
response to 10 µM baclofen in control cells isolated from postnatal rats 6 to 8 days old.
Each bar represents the mean percent change of sustained calcium current. Cells were
classified as demonstrating a decrease (black bar), no change (light gray bar), or an
increase (dark gray bar) in response to 10 µM baclofen.

The distribution of the responses differed in the presence of the PKC fragment 1936 in comparison to the control cells (Figure 5.4; P = 0.003 using a Chi-square). In
control cultures 34.1% of cells demonstrated a decrease in sustained calcium current,

91
29.5% of cells demonstrated no change in sustained calcium current, and 36.4%
demonstrated an increase in sustained calcium current in response to 10 µM baclofen.
When the PKC fragment 19-36 (2 µM) was included in the recording pipette, 28.6% of
cells demonstrated a decrease in sustained calcium current, 60.7% of cells demonstrated
no change in sustained calcium current, and 10.7% of cells demonstrated an increase in
sustained calcium current in response to 10 µM baclofen (P = 0.027 using a Fisher’s
exact test for pairwise comparisons). Data using the PKC pseudosubstrate peptide
inhibitor, PKC fragment 19-36, suggest that PKC may be involved in the signaling
pathway of L-type calcium current facilitation by GABAB receptors.
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Figure 5.4: Effect of the PKC inhibitors, PKC fragment 19-36, GF-109203X, and chelerythrine
chloride on the baclofen responses in hippocampal neurons. The sustained component of calcium
current was measured at the end of a 300 msec depolarizing pulse to +10 mV from a holding
potential of -80 mV. Cells were classified as demonstrating a decrease (black bar), no change
(light gray bar), or an increase (dark gray bar) in sustained calcium current in response to 10 µM
baclofen. Data were collected from 44 control cells, 28 cells in the presence of the PKC fragment
19-36 (2 µM), 28 cells in the presence of GF-109203X (500 nM), and 25 cells in the presence of
chelerythrine chloride (5 µM). P = 0.003 using a Chi-square when comparing all of the groups
together. Pairwise comparisons were done with a Fisher’s Exact Test. * indicates a statistically
significant difference.
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The PKC inhibitor, GF 109203X (also known as bisindolylmaleimide I and Gö
6850) was also used to determine the involvement of PKC in the signal transduction
pathway of GABAB receptor facilitation of L-type calcium current. This inhibitor was
used by Shen and Slaughter (1999) to demonstrate the involvement of PKC in the signal
transduction pathway of GABAB receptor facilitation of L-type calcium current in
salamander retinal neurons. GF-109203X is a competitive inhibitor for ATP binding and
is highly selective for PKC when compared to several different protein kinases (Toullec
et al., 1991; Martiny-Baron et al., 1993). GF-109203X has been shown to inhibit several
PKC isoforms in tissue from rat brain including α, βI, ε, δ, and ζ (Martiny-Baron et al.,
1993) and α, βI, βII, and γ in bovine brain tissue (Table 5; Toullec et al., 1991). In the
study by Toullec and others (1991) GF-109203 inhibited all of the four PKC isoforms
tested (α, βI, βII, and γ) with similar potency, whereas Matiny-Baron and others (1993)
saw inhibition with a ranked order of potency (α > βI > ε > δ > ζ).
Since GF-109203X is membrane permeable, the compound was included in both
the external bath calcium solution and in the baclofen solution. The distribution of the
responses differed in the presence of GF-109203X (500 nM) in comparison to the control
cells (P = 0.003 using a Chi-square). When GF-109203X (500 nM) was present 46.4%
of the cells demonstrated a decrease in sustained calcium current, 50.0% of cells
demonstrated no change in sustained calcium current, and 3.6% of cells demonstrated an
increase in sustained calcium current in response to 10 µM baclofen (Figure 5.4).
Focusing on the facilitatory response, 36.4% of the control cells demonstrated facilitation
of sustained calcium current when treated with 10 µM baclofen, while only 3.6% of cells
demonstrated facilitation of sustained calcium current treated with 10 µM baclofen when
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GF-109203X was included in the external recording solution (P = 0.001 using a Fisher’s
exact test for pairwise comaprison). Only a single cell out of the 28 cells recorded from
demonstrated a 7.51% increase in sustained calcium current with baclofen application
when GF-109203X (500 nM) was included in the recording solutions, which is lower
than the average percent increase for the 16 control cells demonstrating facilitation (18.07
± 2.78%, Figure 5.3).
The last PKC inhibitor used to confirm the involvement of PKC in the signal
transduction pathway of GABAB receptor facilitation of L-type calcium current was
chelerythrine chloride. Chelerythrine chloride is a benzophenanthridine alkaloid that
inhibits PKC by interacting with the catalytic domain (Herbert et al., 1990). This
compound has also been shown to affect PKC translocation from the cytosol to the
plasma membrane (Chao et al., 1998). Chelerythrine chloride is a selective inhibitor of
the conventional PKC isoforms (α, βI, βII, and γ) as well as several of the novel PKC
isoforms and atypical PKC isoforms (Herbert et al., 1990; Liu et al., 1994; Chmura et al.,
2000; Siomboing et al., 2001). Chelerythrine chloride is membrane permeable and
therefore was included in both the external calcium solution and in the baclofen solution.
The distribution of the responses differed in the presence of chelerythrine chloride (5 µM)
in comparison to the control cells (P = 0.003 using a Chi-square). When chelerythrine
chloride was present in the recording solutions, 12.0% of the cells demonstrated a
decrease in sustained calcium current, 80.0% of cells demonstrated no change in
sustained calcium current, and 8.0% of cells demonstrated an increase in sustained
calcium current in response to 10 µM baclofen (Figure 5.4; P = 0.011 using a Fisher’s
exact test for pairwise comparisons). The 2 cells demonstrating facilitation of sustained
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calcium current when treated with 10 µM baclofen in the presence of chelerythrine
chloride exhibited an average percent increase of 9.46%, which is lower than the average
percent increase of the 16 control cells that demonstrated facilitation in response to 10
µM baclofen (18.07 ± 2.78%, Figure 5.3).
All three of the PKC inhibitors used, PKC fragment 19-36, GF-109203X, and
chelerythrine chloride blocked the ability of baclofen to facilitate sustained calcium
current in response to baclofen application. These data all support the hypothesis that
PKC is involved in the pathway of facilitation of L-type calcium current by GABAB
receptor activation. However, PKC inhibition did not block the ability of baclofen to
decrease sustained calcium current, supporting the hypothesis that the decrease of N-type
calcium current by GABAB receptor activation occurs though a different signal
transduction mechanism and is not mediated by PKC.

Activation of PKC by PMA Mimics the Effect of Baclofen to Facilitate Sustained
Current
If a novel or conventional PKC isoform is involved in the signal transduction
pathway of L-type calcium current facilitation by GABAB receptors, activation of PKC
with a phorbol ester should mimic the facilitatory response seen with baclofen
application. Like diacylglycerols, phorbol esters activate PKC by binding to the C1
domain of the PKC regulatory region (Burns and Bell, 1991). PMA is a non-selective,
general PKC activator and has been shown to activate both the conventional and novel
PKC isoforms, but not the atypical PKC isoforms (Riedel et al., 1993a, 1993b; Goode et
al., 1994; Shieh et al., 1995, 1996). PMA was applied to the cells the same way baclofen
was applied as described in Chapter 2 using a U-tube delivery system made out of PE-10
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polyethylene tubing housed in a plexiglass arm. The distribution of the responses
differed when PMA was applied to the cells (1 µM) in comparison to the control cells
where 10 µM baclofen was applied (P = 0.003 using a Chi-square). As seen with
baclofen application, a third of the cells (30.80%) demonstrated facilitation of sustained
calcium current when 1 µM PMA was applied to hippocampal cultures isolated from rat
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Figure 5.5: Effect of the PKC activator PMA on the baclofen responses in hippocampal neurons.
The sustained component of calcium current was measured at the end of a 300 msec depolarizing
pulse to +10 mV from a holding potential of -80 mV. Cells were classified as demonstrating a
decrease (black bar), no change (light gray bar), or an increase (dark gray bar) in response to 10
µM baclofen or 1 µM PMA. Data were collected from 44 cells with baclofen and 26 cells with
PMA application (P = 0.003 using a Chi-square). Pairwise comparisons were done with a
Fisher’s Exact Test. * indicates a statistically significant difference.

that demonstrated facilitation of sustained calcium current in response to PMA
application was 20.11 ± 2.7%, which is consistent with the 16 control cells that
demonstrated an 18.07 ± 2.78 % increase with 10 µM baclofen application (Figure 5.2).
Only a single cell demonstrated a decrease (8.74%) in response to PMA application,
which further suggests that the decrease of calcium current in response to GABAB
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receptor activation is not through a PKC mediated pathway. This experiment using the
PKC activator PMA supports the hypothesis that PKC is involved in the signal
transduction mechanism of L-type calcium current facilitation by GABAB receptors.

PKA inhibitors had varying effects on the facilitation of L-type current by GABAB
receptors
In addition to PKC, Shen and Slaughter (1999) showed that the PKA inhibitor,
Rp-cAMP (50 µM), was able to suppress L-type current facilitation by GABAB receptors
in the salamander retina. Therefore, two different PKA inhibitors, Rp-cAMPS and H-89,
as well as a PKA activator, 8-Br-cAMP, were used to address the involvement of PKA in
the signal transduction pathway of L-type calcium current facilitation by GABAB
receptor activation in rat hippocampus.
PKA is a tetrameric structure composed of two regulatory subunits and two
catalytic subunits. Inhibition of PKA can be achieved by either inactive cAMP analogues
that competitively bind to the cAMP sites on the regulatory subunits or by compounds
that block the ATP binding sites on the catalytic subunits. The two PKA inhibitors used
to investigate the involvement of PKA, were Rp-cAPMS and H-89. Rp-cAMPS, is a
cAMP analogue that has been shown to bind to both type I and type II regulatory subunits
of PKA (Rothermel et al., 1984; Van Haastert et al., 1984; Rothermel and Botelho, 1988;
Dostmann et al., 1990). Binding of Rp-cAMPS to the cAMP sites prevents the
dissociation of the catalytic subunits from the regulatory subunits. Rp-cAMPS has also
been shown to be resistant to cyclic nucleotide phosphodiesterases (Erneux et al., 1988).
In comparison to Rp-cAMPS, H-89 does not prevent dissociation of the catalytic subunits
from the regulatory subunits. Rather, H-89 inhibits the action of PKA by binding to the
ATP pocket on the catalytic subunits (Engh et al., 1996). Since both Rp-cAMPS and H-
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89 are membrane permeable, these compounds were included in the external calcium
solution and in the baclofen solution.
In analyzing both of the PKA inhibitors together and comparing the distribution
with the control cells, there is a significant difference in the distribution of the responses
to baclofen in the absence and presence of PKA inhibitors (Figure 5.6; P = 0.011 using a
Chi-square). However, there were no significant differences in the percentage of cells
demonstrating either inhibition or facilitation of sustained calcium current with 10 µM
baclofen application when Rp-cAMPS was present (Figure 5.6). In contrast to RpcAMP, the percent cells demonstrating an inhibition or facilitation of sustained calcium
current in responses to application of baclofen differed significantly in the presence of H89 (1 µM) in comparison to the control cells (Figure 5.6; decrease, P=0.032; increase, P =
0.001 using a Fisher’s exact test for pairwise comparisons ). H-89 blocked the ability
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Figure 5.6: Effect of the PKA inhibitors, Rp-cAMPS and H-89, on the baclofen responses in
hippocampal neurons. The sustained component of calcium current was measured at the end of a
300 msec depolarizing pulse to +10 mV from a holding potential of -80 mV. Cells were
classified as demonstrating a decrease (black bar), no change (light gray bar), or an increase (dark
gray bar) in response to 10 µM baclofen. Data were collected from 44 control cells, 26 cells in
the presence of Rp-cAMP (30 µM, P = 0.239 using a Chi-square), and 28 cells in the presence of
H-89 (1 µM, P = 0.005). Pairwise comparisons were done with a Fisher’s Exact Test. * indicates
a statistically significant difference.
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of baclofen to facilitate L-type calcium current, but baclofen was still able to facilitate
sustained current in the presence of Rp-cAMPS. Data using H-89 suggest that PKA is
involved in the signal transduction pathway of L-type calcium current facilitation by
GABAB receptors in the rat hippocampus, whereas data using Rp-cAMPS suggest that
PKA is not involved in the signal transduction pathway of L-type calcium current
facilitation by GABAB receptors in the rat hippocampus.

8-Br-cAMP does not Modulate Calcium Currents in the Neonatal Rat Hippocampus
To determine whether PKA activation mimics the modulatory effects of baclofen,
the cell-permeable cAMP analogue 8-Br-cAMP (500 µM) was used. 8-Br-cAMP was
applied to the cells the same way baclofen was applied as described in Chapter 2. The
distribution of the responses differed when 8-Br-cAMP was applied to the cells (500 µM)
in comparison to the control cells in which 10 µM baclofen was applied (Figure 5.7; P <
0.001 using a Chi-square). Most of the cells (91.7%) demonstrated no effect in response
to 500 µM 8-Br-cAMP application, suggesting that PKA is not involved in the signal
transduction mechanism of either the facilitation of L-type calcium current or an
attenuation of N-type current by GABAB receptor activation.
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Figure 5.7: Effect of the PKA activator 8-Br-cAMP on the baclofen responses in hippocampal
neurons. The sustained component of calcium current was measured at the end of a 300 msec
depolarizing pulse to +10 mV from a holding potential of -80 mV. Cells were classified as
demonstrating a decrease (black bar), no change (light gray bar), or an increase (dark gray bar) in
response to 10 µM baclofen or 500 µM 8-Br-cAMP. Data were collected from 44 cells with
baclofen and 24 cells with 8-Br-cAMP application (P < 0.001 using a Chi-square). Pairwise
comparisons were done with a Fisher’s Exact Test. * indicates a statistically significant
difference.
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DISCUSSION
The importance of calcium influx in neuronal function makes it a prime site for
modulation by neurotransmitters and second messengers. Many inhibitory interneuron
subtypes within the hippocampus utilize GABA to regulate the overall excitability of the
hippocampal region. Our laboratory has demonstrated that activation of GABAB
receptors can enhance calcium influx through L-type calcium channels and attenuate
calcium influx through N-type calcium channels during development of the rat
hippocampus (Carter and Mynlieff, 2004). GABAB receptors are metabotropic and often
regulate calcium or potassium channels through activation of G-proteins. There are
several mechanisms of calcium channel modification through both direct and indirect
signaling pathways. One of the most common signaling pathways associated with
GABAB receptor activation is through Gi/o proteins (Morishita et al., 1990; Campbell et
al., 1993; Menon-Johansson et al., 1993; Greif et al., 2000). Both N-type and P/Q-type
calcium current inhibition generally occurs through direct modulation by Gβγ subunits,
which are sensitive to PTX suggesting the involvement of Gi/o proteins (Kleuss et al.,
1991; Herlitze et al., 1996; Ikeda et al., 1996; Furukawa et al., 1998; Zamponi and
Snutch, 1998; Kajikawa et al., 2001; Mirshahi et al., 2002). In the current study,
treatment with PTX in hippocampal cultures isolated from 7 day old rats blocks the
ability of baclofen to decrease calcium current, which has been shown to be through Ntype calcium channels (Carter and Mynlieff, 2004). This is consistent with other studies
that have demonstrated the involvement of Gi/o proteins in the attenuation of N-type
calcium current by GABAB receptor activation in other regions of the rat brain, such as
cerebellar granule neurons, cerebrocortical synaptosomes, supraoptic neurons, and
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hippocampal pyramidal neurons (Amico et al., 1995; Santos et al., 1995; Harayama et al.,
1998; Bertrand et al., 2003). The signal transduction mechanism of L-type calcium
current facilitation by GABAB receptors in the rat hippocampus is not known.
Facilitation of L-type calcium current by GABAB receptors was still seen in the presence
of PTX, which suggests that Gi/o proteins are not involved in the signaling pathway of Ltype calcium current facilitation by GABAB receptors and that another mechanism must
be involved.
L-type calcium channels have several consensus sites for regulation by protein
kinases. Therefore, the involvement of both PKC and PKA in the pathway was
investigated using several inhibitors and activators for each kinase. Shen and Slaughter
(1999) demonstrated that GABAB receptor activation can lead to the facilitation of L-type
calcium current in a subset of salamander retinal neurons. Approximately 43% of the
cells they tested showed a facilitatory response to application of 500 nM baclofen. In
their study, the facilitation of L-type calcium current was blocked in the presence of the
PKC inhibitors GF-109203X and PKC fragment 19-36. In comparison to the PKC
inhibitors, the PKA inhibitor Rp-cAMP only partially suppressed the facilitation of Ltype calcium current. Their study suggested that PKC appears to be more important than
PKA in the signaling pathway of GABAB receptor modulation of L-type current in the
salamander retina (Shen and Slaughter, 1999).
Our lab was the first to demonstrate the facilitation of L-type calcium current
through GABAB receptor modulation in the mammalian CNS (Carter and Mynlieff,
2004). In the present study, we have demonstrated that PKC is involved in the pathway
of L-type calcium current facilitation by GABAB receptors. Several broad-spectrum PKC
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inhibitors were used to verify the involvement of PKC in the pathway. All three PKC
inhibitors used, PKC fragment 19-36, GF-109203X, and chelerythrine chloride blocked
the ability of baclofen to facilitate L-type calcium current in hippocampal cultures
isolated from 6 to 8 day old rats. These PKC inhibitors were chosen based on their
specificity to several if not all of the PKC isoforms, their cell permeability, and their
varying chemical structures. To further confirm the involvement of PKC, a phorbol ester,
PMA, was used to activate PKC and the responses to sustained calcium current were
measured. Facilitation was observed with PMA application in 30.80% of the cells, which
is consistent with the 36.36% of cells that demonstrated facilitation with baclofen
application. All of these data suggest that PKC is involved in the signal transduction
pathway of L-type calcium current facilitation by GABAB receptors in the neonatal rat
hippocampus.
Future experiments in the laboratory will explore the involvement of specific
PKC isoforms in the pathway. The fact that the facilitatory response is present in
hippocampal cultures isolated from postnatal day 7, suggests that some of the PKC
isoforms that are expressed later in development may not be involved. The study by
Roisin and Barbin (1997), which explored the presence of several PKC isoforms during
hippocampal development, suggests that PKCγ is probably not involved in the signaling
pathway. PKCγ levels remain relatively low for the first postnatal week and only begin
to rise following postnatal day 7 (Roisin and Barbin, 1997). All of the other PKC
isoforms tested, α, β, ε, and ζ were highly expressed by postnatal day 7. Therefore, each
of these isoforms could be involved in the pathway of GABAB receptor mediated
facilitation of L-type calcium current. Activation of PKC with PMA mimicked the
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facilitation normally seen with baclofen application, which suggests that either
conventional or novel PKC isoforms are involved in the pathway rather than the atypical
isoforms.
Facilitation was still seen in the presence of the PKA inhibitor, Rp-CAMP, but
not when the PKA inhibitor H-89 was used. The varying responses seen with the PKA
inhibitors could be due to several reasons. Rp-cAMPS and H-89 were chosen, because
they are both membrane permeable inhibitors of PKA. However, they inhibit PKA
through two very different mechanisms. Rp-cAMPS prevents the dissociation of the
catalytic subunit from the regulatory subunit by competitively binding to the cAMP sites
on the regulatory subunit. This inhibitor blocks the activation of the catalytic subunit all
together and thus dissociation from the regulatory site. In comparison, H-89 associates
with the ATP binding site on the catalytic subunit and blocks the phosphorylation
processes of PKA. Even though H-89 is a potent inhibitor for PKA (Chijiwa et al.,
1990), it has been shown to inhibit several other kinases including p70 ribosomal protein
S6 kinase 1 (S6K1; IC50 = 80 nM), mitogen- and stress-activated protein kinase (MSK1;
IC50 = 120 nM), PKG (IC50 = 340 nM), CaMKII (IC50 = 11 µM), and PKC (IC50 = 14
µM; Davies et al., 2000, for review see Lochner and Moolman, 2006). Thus, it is
possible that H-89 is inhibiting other kinases, which is causing variation in the calcium
current responses seen to baclofen application when compared to the other PKA inhibitor
used. Direct activation of PKA with 8-Br-cAMP did not result in the facilitation of Ltype calcium current, which suggests that PKA is not involved in the signal transduction
pathway of L-type calcium current by GABAB receptor activation.
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In conclusion, during the early neonatal period in the rat hippocampus GABAB
receptor activation can lead to the attenuation of N-type calcium current and the
facilitation of L-type calcium current. The current study has demonstrated that the
attenuation of N-type calcium current by GABAB receptor activation is mediated through
a PTX sensitive G-protein pathway. Attenuation of N-type calcium current was still
observed in the presence of PKC and PKA inhibitors and attenuation of N-type calcium
current was not seen with direct activation of PKC and PKA. These experiments suggest
that neither PKC nor PKA are involved in the pathway of N-type calcium current
modulation by GABAB receptors. Facilitation of L-type calcium current was still
observed in the presence of PTX, which demonstrated that Gi/o proteins were not
involved in the pathway. Facilitation of L-type calcium current was not seen in the
presence of PKC inhibitors and facilitation was observed with direct activation of PKC
with a phorbol ester. These experiments suggest that PKC is involved in the pathway of
L-type calcium current facilitation by GABAB receptor activation in the rat hippocampus.
Facilitation was still observed in the presence of Rp-cAMP, but not in the presence of
another PKA inhibitor H-89. Direct activation of PKA with a cAMP analogue, 8-BrcAMP, did not result in the facilitation of L-type calcium current. Therefore, the results
using Rp-cAMP and 8-Br-cAMP suggest that PKA is not involved in the signal
transduction pathway of L-type calcium current facilitation by GABAB receptors.
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CHAPTER 6
GENERAL DISCUSSION
The primary findings presented in these studies demonstrate that the facilitation of
L-type calcium current by GABAB receptor activation is more prominent in the second
postnatal week when compared to the first postnatal week of hippocampal development
in the rat. In comparison, the inhibition of N-type calcium current was found to be more
prominent during the first postnatal week when compared to the second postnatal week of
hippocampal development. The facilitation of L-type calcium current was blocked in the
presence of PKC inhibitors and the response was mimicked with direct activation of PKC
with a phorbol ester. Time course studies using Western blot analysis demonstrated that
KCC2 protein levels increase during the first two postnatal weeks, while NKCC1 protein
levels remain relatively level in both hippocampal cultures and whole hippocampal
protein extracts of rat pups. Calcium influx through L-type calcium channels was shown
to be necessary at least in part for the upregulation of KCC2 protein levels.
The hippocampus contains excitatory pyramidal neurons and over 21 different
types of inhibitory interneurons. Approximately 30% of the cells in hippocampal
cultures isolated from pups 7 to 14 days old demonstrate facilitation of L-type calcium
current. Due to the heterogeneity of hippocampal cell cultures, it is possible the
facilitatory response of calcium current by GABAB receptors is only observed in a
particular subset of cells. A study by Nuñez and McCarthy (2007), demonstrated peak
protein levels of the L-type calcium channel subtype Cav1.2 in hippocampal protein
extracts isolated from 7 day old rat pups. Previous immunocytochemical experiments in
the Mynlieff laboratory have demonstrated that only about 30% of the neurons in our
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cultures express Cav1.2, whereas almost all of the neurons express Cav1.3. Preliminary
data using Western blot analysis of membrane proteins isolated from the superior region
of hippocampi from rats of varying ages demonstrate that Cav1.2 levels are high in the
first postnatal week, whereas Cav1.3 protein levels begin low and increase throughout
neonatal development (Ingraham, unpublished data). The early expression of Cav1.2 and
its restriction to a subset of cells suggest that Cav1.2 rather than Cav1.3 is involved in the
facilitatory response of calcium current by GABAB receptors.
The data presented indicate that PKC is involved in the signaling pathway of Ltype calcium current facilitation by GABAB receptors. Furthermore, this effect is likely
to be mediated by a conventional or novel isoform of PKC rather than an atypical form
since the effect of baclofen on L-type current was mimicked by the PKC activator, PMA.
However, PKC may not directly phosphorylate L-type calcium channels to produce this
response. Rather than direct phosphorylation of the calcium channel, PKC may
phosphorylate another intermediate effector protein. For example, the enhancement of Ltype calcium current has been observed in isolated rat ventricular myocytes by activation
of α1A adrenoceptors. This enhancement of L-type calcium current was mediated through
a PKC and CaMKII pathway (O-Uchi et al., 2005, 2008). Several other studies in cardiac
and smooth muscle myocytes have suggested that CaMKII is involved in a calciumdependent facilitation of L-type calcium current (McCarron et al., 1992; Anderson et al.,
1994; Yuan and Bers, 1994). Thus, it is possible that PKC may phosphorylate and
activate CaMKII to facilitate L-type calcium current in the rat hippocampus (Figure 6.1).
Additional studies in the laboratory will utilize CaMKII inhibitors, to investigate the
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involvement of the kinase in the pathway of L-type calcium current facilitation by
GABAB receptors.
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Figure 6.1: Possible signal transduction pathway of L-type calcium current
facilitation by GABAB receptors. Abbreviations:
PIP2, phosphoinositol
bisphosphate; PLC, phospholipase C; DAG, diacylglycerol; PKC, protein kinase
C; IP3, inositol trisphosphate; CaMKII, calcium/calmodulin dependent kinase II.

The facilitation of L-type calcium current has been observed in several different
cell types, including skeletal muscle, cardiac muscle, smooth muscle, neurons, and
adrenal chromaffin cells. The enhancement of L-type calcium current increases the force
of contraction during tetanic stimulation in skeletal muscle (Schmid et al., 1985; Arreloa
et al., 1987; Sculptoreanu et al., 1993a) and also increases the force of contraction in
cardiac muscle during physiological increases in heart rate (Lee, 1987; Zygmunt and
Maylie, 1990; Sculptoreanu et al., 1993b; Kamp et al., 2000). In neurons, L-type calcium
current facilitation can contribute to changes in neuronal excitability and synaptic
plasticity (Kavalali and Plummer, 1996; Parri and Lansman, 1996; Kammermeier and
Jones, 1998). Facilitation of L-type calcium current also plays an important role in
adrenal chromaffin cells by inducing catecholamine release (Hoshi et al., 1984; Artalejo
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et al., 1992). These are just a few examples of the importance L-type calcium current
facilitation plays in many native cell types.
Calcium influx through VDCCs and NMDA receptors is crucial in developing
neurons. Calcium signaling is involved in the proliferation, migration, and differentiation
of neurons (Marty et al., 1996). Calcium influx also plays an important role in
synaptogenesis and the integration of new synapses into neuronal networks (Eins et al.,
1983; Kneussel and Betz, 2000). An increase in gene expression and DNA synthesis is
also observed as a result of the increase in calcium levels (West et al., 2001). It is
possible that the enhancement of L-type calcium current in response to GABAB receptor
activation could be playing a very specific and important role in one of these responses,
such as signaling changes in gene expression. The occurrence of L-type calcium current
facilitation in the early neonatal period suggests that calcium influx plays a functional
role in the maturation process of hippocampal neurons.
GABA is the main inhibitory neurotransmitter in mature neurons, but its effects
are excitatory in immature neurons. The excitatory actions of GABA during
development have been demonstrated in several brain regions, including the
hippocampus (Mueller et al., 1984; Ben-Ari et al., 1989; Cherubini et al., 1990;
Leinekugel et al., 1995; Khazipov et al., 1997; Ganguly et al., 2001), cerebellum ( Eilers
et al., 2001), neocortex (Luhmann and Prince, 1991; Yuste and Katz, 1991; Fukuda et al.,
1998; Owens et al., 1999), and the hypothalamus (Chen et al., 1996; Obrietan and Van
Den Pol, 1999; Gao and Van Den Pol, 2001). Interestingly, GABA and glycine exert
excitatory actions in the developing spinal cord as well (Serafini et al., 1995; Wang et al.,
1994; Vinay and Clarac, 1999). The excitatory response of GABA during development
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plays a critical role in the proliferation, migration, and differentiation of neurons and also
in the formation of synapses (for review see Ben-Ari, 2002; Owens, 2002).
The excitatory actions of GABA depend on the location, type, and developmental
stage of the neuron. The switch from excitatory-to-inhibitory may occur at different
developmental stages in the various brain regions and even occur at different stages for
the various cell types found within a single region. For example, in the hippocampus it is
suggested that the excitatory-to-inhibitory switch occurs in inhibitory interneurons before
pyramidal cells. Studies by Hennou and colleagues (2002) have demonstrated the
sequential development of GABAergic and then glutamatergic synapse formation in CA1
hippocampal interneurons in rats. It is possible that the GABAergic switch even within
different groups of interneurons can occur at different developmental stages (Hennou et
al., 2002). Similarly, GABA synapses precede the formation of glutamatergic synapses
in rat hippocampal CA1 pyramidal neurons (Tyzio et al., 1999). In patch clamp
recordings from hippocampal slices isolated from postnatal day 0 rats, three different
populations of CA1 pyramidal cells were observed (Tyzio et al., 1999). There are
pyramidal cells that have functional GABAA and glutamate receptors, but are silent and
do not exhibit excitatory postsynaptic currents (PSCs). There are cells that just exhibit
GABA mediated excitatory PSCs, while the last group of cells exhibits both GABA and
glutamate mediated excitatory PSCs. The group of cells that exhibit both GABA and
glutamate PSCs are more developed than the other two groups and contain both an apical
and basal dendrite (Tyzio et al., 1999; for review see Ben-Ari, 2002). The fact that
GABAergic synapses are formed on interneurons prior to pyramidal cells, suggests that
the excitatory actions of GABA and subsequent influx of calcium may play an important
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role in the maturation of interneurons, which subsequently aids in the maturation of
pyramidal neurons.
In immature neurons, GABAA receptor activation can depolarize the membrane
and increase intracellular calcium levels through activation of L-type calcium channels
(Yuste and Katz, 1991; Leinekugel et al., 1995; Ganguly et al., 2001). Long lasting
depolarizing potentials called giant depolarizing potentials (GDPs) are also observed
during the first two postnatal weeks in rat hippocampal interneurons and CA3 and CA1
pyramidal neurons and are only present when GABA is excitatory (Ben-Ari et al., 1989;
Leinekugel et al., 1995, 1997, 1998; Khazipov et al., 1997). Glutamatergic synapses also
contribute to GDPs with the activation of NMDA receptors, which further increase
calcium levels in immature neurons. These large oscillations of intracellular calcium
levels aid in neuronal growth and synapse formation (for review see Ben-Ari, 2002;
Owens and Kriegstein, 2002). Inhibition by GABAB receptors plays an important role in
controlling the duration of the GDPs (Mclean et al., 1996; Caillard et al., 1998).
Whether or not GABA exerts an excitatory response early in development is
largely dependent on the reversal potential for chloride. In mature neurons, intracellular
chloride levels are relatively low. Therefore, GABAA receptor activation results in
chloride influx and hyperpolarizes the neuron. In immature neurons, intracellular
chloride levels are higher than in mature neurons. GABAA receptor activation in an
immature neuron results in chloride efflux and depolarizes the neuron. It is thought that
the changes in the intracellular chloride levels are mediated by developmental changes in
the expression of the specific chloride cotransporters, NKCC1 and KCC2. NKCC1
predominates in the early neonatal period and mediates chloride influx, while KCC2
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expression predominates in mature neurons and mediates chloride efflux. KCC2 protein
levels increase during the first two postnatal weeks, while NKCC1 protein levels remain
relatively level in both hippocampal cultures and whole hippocampal protein extracts of
rat pups. NKCC1 expression is critical during the early neonatal period, however
because protein levels remain level throughout the first two weeks of development this
cotransporter does not appear to be solely responsible for the GABAergic switch. Our
study was the first to compare the protein levels of both NKCC1 and KCC2 throughout
hippocampal development to determine a ratio of the two transporters. Rather than the
upregualtion of KCC2 and the downregualtion of NKCC1 protein, the data presented
here suggest that it is the ratio of KCC2 to NKCC1 that is important for the
developmental switch of the GABAA response.
One of the biggest questions in the developmental regulation of the reversal
potential for chloride is what signals are involved in the increase in KCC2 expression
during the early neonatal period. Do the excitatory actions of GABA itself trigger the
cascade through the increase of intracellular calcium levels? Ganguly et al., (2001)
demonstrated that calcium influx is necessary for the excitatory-to-inhibitory switch of
GABAA receptors during the early postnatal period. In addition, they observed a
decrease in KCC2 mRNA with the blockade of GABAA receptors (Ganguly et al., 2001).
The current study has demonstrated that calcium influx through L-type calcium channels
is necessary for the upregulation of KCC2 protein levels. Inhibition of L-type calcium
channels with nimodipine blocked the upregulation of KCC2 protein levels in
hippocampal cultures by 50%. Together, these studies demonstrate that GABAA
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excitation and calcium influx through L-type calcium channels is necessary for the
upregulation of KCC2 and the subsequent switch in the GABAergic response.
Increases in the phosphorylated form of the transcription factor, cAMP response
element-binding protein (pCREB), are observed with GABAA receptor activation during
the first postnatal week and this effect is blocked by L-type calcium channel antagonists
(Perrot-Sinal et al., 2003; Mantelas et al., 2007; Nuñez and McCarthy, 2007). GABA
induced increases in intracellular calcium levels, which activate pCREB, can induce
BDNF expression (Berninger et al., 1995; Obrietan et al., 2001; West et al., 2001).
BDNF levels are higher in the first two postnatal weeks of development and BDNF may
play an important role in the maturation of the GABAergic system. It has been
demonstrated that overexpression of BDNF can increase the amount of GABAergic
synapses early in development and also increase KCC2 mRNA levels in transgenic
embryos (Aguado et al., 2003). Interneurons do not express BDNF. Therefore, it is
possible that the release of BDNF from pyramidal cells aids in the upregulation of KCC2
in interneurons. Therefore, BDNF could either increase KCC2 levels in the neuron
expressing it or bind to BDNF receptors (trkB) on neighboring interneurons that would
lead to an increase of KCC2 expression in these cells. In addition to activation of
transcription factors and neurotrophins, L-type calcium current has also been shown to
activate kinases such as CaMKII, which could be involved in the phosphorylation of
CREB and the increase in BDNF expression (West et al., 2001). Thus, it is possible that
activation of neurotrophins, transcription factors, and kinases by calcium influx through
L-type calcium channels could all be involved in gene activation and trigger the
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upregualtion of KCC2 during the early neonatal period in either pyramidal neurons or
interneurons in the hippocampus (Figure 6.2).
The increase in calcium current is also involved in membrane trafficking and
posttranslational changes in addition to changes in gene transcription and protein
synthesis. In a study by Fiumelli et al., (2005), the shift in the chloride reversal potential
was not observed in the presence of Ca2+-dependent PKC inhibitors. Direct
phosphorylation of KCC2 by PKC decreases endocytosis of KCC2 proteins, thus
enhancing KCC2 protein levels in the membrane (~200% increase, Lee et al., 2007).
Therefore, it is possible that activation of PKC by L-type calcium current could be
regulating membrane trafficking of the KCC2 transporter (Figure 6.2).
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Figure 6.2: Possible signaling events involved in the upregualtion of KCC2. GABA mediated
increases in L-type calcium current could activate a signaling cascade involving several steps
resulting in the upregualtion of KCC2. In addition, activation of PKC by L-type calcium current
can decrease endocytosis thereby decreasing the degradation of KCC2 protein in these neurons.
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There are still many questions to be answered regarding the signal transduction
mechanism of L-type calcium current facilitation by GABAB receptors during the early
neonatal period in the rat hippocampus. Since PKC is involved in the mechanism of Ltype current facilitation it is possible that GABAB receptors are coupled to Gαq/11 and
PLC in a subset of neurons in the neonatal rat hippocampus. Inhibitors of PLC and the
selective Gαq/11 inhibitor (YM-254890) could be used to investigate the coupling of
GABAB receptors to Gαq/11 and PLC in neonatal rat hippocampal cultures using
electrophysiological recording or calcium imaging. The association of GABAB receptors
with Gαq/11 would be a novel finding, because GABAB receptors predominantly couple to
Gαi/o proteins (Morishita et al., 1990; Campbell et al., 1993; Menon-Johansson et al.,
1993; Greif et al., 2000).
Future experimentation could also investigate the involvement of CaMKII in the
pathway of L-type calcium current facilitation in the rat hippocampus, since the
enhancement of calcium influx through Cav1.2 channels in cardiac myocytes has been
shown to be mediated through a PKC / CaMKII pathway. To determine whether
CaMKII is involved in the signal transduction pathway of L-type calcium current
facilitation by GABAB receptors, whole-cell patch clamp recording and calcium imaging
in hippocampal neurons could be performed in the presence of CaMKII inhibitors. If
facilitation by GABAB receptors was no longer observed in the presence of CaMKII
inhibitors, it would suggest that CaMKII is involved in the facilitatory pathway along
with PKC.
In addition, the specific PKC isoforms involved in the signaling mechanism have
not been identified. Since the atypical PKC isoforms do not have a DAG binding site and
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are not activated by phorbol esters, it is highly unlikely that they are involved in the
facilitation of L-type calcium channels by GABAB receptors in this subset of cells. The
involvement of conventional and novel PKC isoforms in the pathway could be
investigated using similar electrophysiological experiments that were performed with the
general PKC inhibitors presented here, but rather with specific inhibitors of the different
PKC isoforms. Calcium imaging, which provides much faster data acquisition than
electrophysiological recording, could also be used to test the effects of kinase inhibition
on the baclofen responses seen in hippocampal cultures. In addition, Western blot
analysis using antibodies against the phosphorylated states of specific PKC isoforms with
baclofen treatment could also be used to investigate the PKC isoform involved. Further
studies using Western blot analysis could also be used to determine the translocation of
the conventional and novel PKC isoforms to the membrane with baclofen treatment.
Several studies have suggested that the Cav1.2 rather than the Cav1.3 L-type
calcium channel is facilitated by GABAB receptor activation in neonatal rat hippocampus.
Through immunohistochemical experiments and confocal micrscopy in hippocampal
slices, it could be determined if Cav1.2 L-type calcium channels colocalize with GABAB
receptors, and specifically which subtype of the GABAB receptor is involved: GABAB1a
which is located presynaptically or GABAB1b which is primarily located postsynaptically
(Vigot et al., 2006). The developmental changes of L-type channels and GABAB
receptor expression could also be observed through immunohistochemical analysis.
Using a Zeiss Pascal confocal microscope equipped with two laser lines and
fluorescence, the specific subcellular localization of antibody staining could be
thoroughly analyzed. Since L-type current facilitation by GABAB receptor activation is a
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developmental phenomenon that predominates during the second postnatal week, it is
likely that L-type calcium channels may only be colocalized with GABAB receptors early
in neonatal development and not in adult rats. Further confirmation of the involvement
of Cav1.2 could involve electrophysiological recording in hippocampal cultures in the
absence of Cav1.2 channels. Short hairpin RNA knockdown of the Cav1.2 α1 subunit in
dorsal horn neurons has been shown to effectively decrease expression of the channel in
the membrane (Fossat et al., 2010). If the Cav1.2 gene is effectively silenced, GABAB
receptors would no longer be able to facilitate L-type calcium current in hippocampal
neurons.
Using hippocampal slices, it could be possible to identify the subset of cells in
which L-type calcium channels and GABAB receptors are colocalized. Inhibitory
interneurons within the hippocampus are highly diverse, but different types of
interneurons can be identified based on morphology. Somatic location within a layer as
well as dendritic shape can aid in the identification of an interneuron class. Molecular
cell markers such as calcium binding protein, parvalbumin, cholecystokinin, and
vesicular glutamate transporter 3 can also be used to identify interneuron classes
(Somogyi and Klausberger, 2005; Klausberger and Somogyi, 2008). However, a single
molecular marker, such as parvalbumin, could not be used to identify an interneuron class
on its own, because many of the interneuron classes can express the same molecular
markers. Therefore, both morphological characteristics and antibody labeling would
have to be utilized to determine if and which specific class of interneurons GABAB
receptors colocalize with L-type calcium channels. A single hippocampal slice could be
labeled with antibodies against GABAB receptors, Cav1.2 L-type calcium channels, and
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an interneuron marker to distinguish which subset of cells GABAB receptors and L-type
calcium channels are colocalized. It would be interesting to determine the specific subset
of cells where GABAB receptors and L-type calcium channels are colocalized, because it
could provide further indications as to the functional significance of L-type calcium
current facilitation by GABAB receptors during development. It is possible that the class
of cells in which GABAB receptors and L-type calcium channels are colocalized may be
specifically important in the time course of the maturation of interneurons and pyramidal
cells.
Together, the experiments presented here along with the proposed experiments
would further our knowledge of the molecular mechanisms that control excitatory and
inhibitory synapse maturation in the developing rat hippocampus.
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